# EDGAR Filing Document

**Accession Number:** 0001084961
**File Stem:** 0001084961-26-000039
**Filing Date:** 2026-5
**Character Count:** 199615
**Document Hash:** d1e40f1bc568c60d7874e99e5e99cfc2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001084961-26-000039.hdr.sgml**: 20260506

**ACCESSION NUMBER**: 0001084961-26-000039

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 76

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260506

**DATE AS OF CHANGE**: 20260506

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ENCORE CAPITAL GROUP INC
- **CENTRAL INDEX KEY:** 0001084961
- **STANDARD INDUSTRIAL CLASSIFICATION:** SHORT-TERM BUSINESS CREDIT INSTITUTIONS [6153]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 481090909
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-26489
- **FILM NUMBER:** 26949772

**BUSINESS ADDRESS:**
- **STREET 1:** 350 CAMINO DE LA REINA
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92108
- **BUSINESS PHONE:** 1-877-345-3002

**MAIL ADDRESS:**
- **STREET 1:** 350 CAMINO DE LA REINA
- **STREET 2:** SUITE 100
- **CITY:** SAN DIEGO
- **STATE:** CA
- **ZIP:** 92108

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MCM CAPITAL GROUP INC
- **DATE OF NAME CHANGE:** 19990430

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MIDLAND CORP OF KANSAS
- **DATE OF NAME CHANGE:** 19990423

?xml version='1.0' encoding='ASCII'? ecpg-20260331

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**WASHINGTON, D.C. 20549** 

___________________________________________________________________________________

**FORM 10-Q** 

(Mark One)

☒&nbsp;&nbsp;&nbsp;&nbsp;**QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the quarterly period ended March 31, 2026 or

☐&nbsp;&nbsp;&nbsp;&nbsp;**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934** 

For the transition period from __________to__________.

COMMISSION FILE NUMBER: 000-26489

**ENCORE CAPITAL GROUP, INC.** 

**(Exact name of registrant as specified in its charter)** 

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Delaware** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**48-1090909** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(State or other jurisdiction of incorporation or organization)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(IRS Employer** <br>**Identification No.)** |

---

**350 Camino De La Reina, Suite 100** 

**San Diego, California 92108** 

**(Address of principal executive offices, including zip code)**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(877) 345-3002** 

**(Registrant's telephone number, including area code)** 

**(Not Applicable)**

**(Former name, former address and former fiscal year, if changed since last report)** 

_______________________________________________________________

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Title of each class** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Trading Symbol(s)** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Name of each exchange on which registered** |
| Common Stock, $0.01 Par Value Per Share | ECPG | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| Large accelerated filer | ☒ | Accelerated filer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ | Non-accelerated filer | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ | Smaller reporting company | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ |
| Emerging growth company | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;☐ | | | | | | |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;&nbsp;&nbsp;☐&nbsp;&nbsp;&nbsp;&nbsp;

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&nbsp;&nbsp;&nbsp;&nbsp;Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

---

| | |
|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Class** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**Outstanding at April 29, 2026** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common Stock, $0.01 par value | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;21,440,412 shares |

---

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**INDEX TO FORM 10-Q**

---

| | |
|:---|:---|
| | **Page** |
| **[PART I – FINANCIAL INFORMATION](#i41c4164d9e084f6a9251d45bf30001ea_13)** | <u>[3](#i41c4164d9e084f6a9251d45bf30001ea_13)</u> |
| <u>[Item 1— Condensed Consolidated Financial Statements (Unaudited)](#i41c4164d9e084f6a9251d45bf30001ea_16)</u> | <u>[3](#i41c4164d9e084f6a9251d45bf30001ea_16)</u> |
| <u>[Condensed Consolidated Statements of Financial Condition](#i41c4164d9e084f6a9251d45bf30001ea_19)</u> | <u>[3](#i41c4164d9e084f6a9251d45bf30001ea_19)</u> |
| <u>[Condensed Consolidated Statements of Income](#i41c4164d9e084f6a9251d45bf30001ea_22)</u> | <u>[4](#i41c4164d9e084f6a9251d45bf30001ea_22)</u> |
| <u>[Condensed Consolidated Statements of Comprehensive Income](#i41c4164d9e084f6a9251d45bf30001ea_25)</u> | <u>[5](#i41c4164d9e084f6a9251d45bf30001ea_25)</u> |
| <u>[Condensed Consolidated Statements of Equity](#i41c4164d9e084f6a9251d45bf30001ea_28)</u> | <u>[6](#i41c4164d9e084f6a9251d45bf30001ea_28)</u> |
| <u>[Condensed Consolidated Statements of Cash Flows](#i41c4164d9e084f6a9251d45bf30001ea_31)</u> | <u>[7](#i41c4164d9e084f6a9251d45bf30001ea_31)</u> |
| <u>[Notes to Condensed Consolidated Financial Statements](#i41c4164d9e084f6a9251d45bf30001ea_34)</u> | <u>[8](#i41c4164d9e084f6a9251d45bf30001ea_34)</u> |
| <u>[Note 1: Ownership, Description of Business, and Summary of Significant Accounting Policies](#i41c4164d9e084f6a9251d45bf30001ea_37)</u> | <u>[8](#i41c4164d9e084f6a9251d45bf30001ea_37)</u> |
| <u>[Note 2: Earnings Per Share](#i41c4164d9e084f6a9251d45bf30001ea_40)</u> | <u>[9](#i41c4164d9e084f6a9251d45bf30001ea_40)</u> |
| <u>[Note 3: Fair Value Measurements](#i41c4164d9e084f6a9251d45bf30001ea_43)</u> | <u>[10](#i41c4164d9e084f6a9251d45bf30001ea_43)</u> |
| <u>[Note 4: Derivatives and Hedging Instruments](#i41c4164d9e084f6a9251d45bf30001ea_46)</u> | <u>[12](#i41c4164d9e084f6a9251d45bf30001ea_46)</u> |
| <u>[Note 5: Receivable Portfolios, Net](#i41c4164d9e084f6a9251d45bf30001ea_49)</u> | <u>[13](#i41c4164d9e084f6a9251d45bf30001ea_49)</u> |
| <u>[Note 6: Other Assets](#i41c4164d9e084f6a9251d45bf30001ea_52)</u> | <u>[15](#i41c4164d9e084f6a9251d45bf30001ea_52)</u> |
| <u>[Note 7: Borrowings](#i41c4164d9e084f6a9251d45bf30001ea_55)</u> | <u>[15](#i41c4164d9e084f6a9251d45bf30001ea_55)</u> |
| <u>[Note 8: Variable Interest Entities](#i41c4164d9e084f6a9251d45bf30001ea_61)</u> | <u>[19](#i41c4164d9e084f6a9251d45bf30001ea_61)</u> |
| <u>[Note 9: Accumulated Other Comprehensive Loss](#i41c4164d9e084f6a9251d45bf30001ea_64)</u> | <u>[20](#i41c4164d9e084f6a9251d45bf30001ea_64)</u> |
| <u>[Note 10: Income Taxes](#i41c4164d9e084f6a9251d45bf30001ea_67)</u> | <u>[19](#i41c4164d9e084f6a9251d45bf30001ea_67)</u> |
| <u>[Note 11: Commitments and Contingencies](#i41c4164d9e084f6a9251d45bf30001ea_70)</u> | <u>[20](#i41c4164d9e084f6a9251d45bf30001ea_70)</u> |
| <u>[Note 12: Segment and Geographic Information](#i41c4164d9e084f6a9251d45bf30001ea_73)</u> | <u>[21](#i41c4164d9e084f6a9251d45bf30001ea_73)</u> |
| <u>[Note 13: Goodwill](#i41c4164d9e084f6a9251d45bf30001ea_76)</u> | <u>[22](#i41c4164d9e084f6a9251d45bf30001ea_76)</u> |
| <u>[Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations](#i41c4164d9e084f6a9251d45bf30001ea_79)</u> | <u>[23](#i41c4164d9e084f6a9251d45bf30001ea_79)</u> |
| <u>[Item 3 – Quantitative and Qualitative Disclosures About Market Risk](#i41c4164d9e084f6a9251d45bf30001ea_130)</u> | <u>[41](#i41c4164d9e084f6a9251d45bf30001ea_130)</u> |
| <u>[Item 4 – Controls and Procedures](#i41c4164d9e084f6a9251d45bf30001ea_133)</u> | <u>[41](#i41c4164d9e084f6a9251d45bf30001ea_133)</u> |
| **[PART II – OTHER INFORMATION](#i41c4164d9e084f6a9251d45bf30001ea_136)** | <u>[42](#i41c4164d9e084f6a9251d45bf30001ea_136)</u> |
| <u>[Item 1 – Legal Proceedings](#i41c4164d9e084f6a9251d45bf30001ea_139)</u> | <u>[42](#i41c4164d9e084f6a9251d45bf30001ea_139)</u> |
| <u>[Item 1A – Risk Factors](#i41c4164d9e084f6a9251d45bf30001ea_142)</u> | <u>[42](#i41c4164d9e084f6a9251d45bf30001ea_142)</u> |
| <u>[Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds](#i41c4164d9e084f6a9251d45bf30001ea_145)</u>  | <u>[42](#i41c4164d9e084f6a9251d45bf30001ea_145)</u> |
| <u>[Item 5 – Other Information](#i41c4164d9e084f6a9251d45bf30001ea_148)</u> | <u>[42](#i41c4164d9e084f6a9251d45bf30001ea_148)</u> |
| <u>[Item 6 – Exhibits](#i41c4164d9e084f6a9251d45bf30001ea_154)</u> | <u>[43](#i41c4164d9e084f6a9251d45bf30001ea_154)</u> |
| <u>[SIGNATURES](#i41c4164d9e084f6a9251d45bf30001ea_157)</u> | <u>[44](#i41c4164d9e084f6a9251d45bf30001ea_157)</u> |

---

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**PART I – FINANCIAL INFORMATION**

**Item 1—Condensed Consolidated Financial Statements (Unaudited)**

**ENCORE CAPITAL GROUP, INC.**

**Condensed Consolidated Statements of Financial Condition**

(In Thousands, Except Par Value Amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Cash and cash equivalents | $227204 | $156784 |
| Receivable portfolios, net | 4437415 | 4371532 |
| Property and equipment, net | 79292 | 82080 |
| Other assets | 177163 | 193113 |
| Goodwill | 529487 | 536291 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total assets | $5450561 | $5339800 |
| **Liabilities and Equity** |  |  |
| Liabilities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | $252277 | $230261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowings | 4033301 | 4001293 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities | 130175 | 131496 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities | 4415753 | 4363050 |
| Commitments and contingencies (Note 11) |  |  |
| Equity: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible preferred stock, $0.01 par value, 5,000 shares authorized, no shares issued and outstanding |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Common stock, $0.01 par value, 75,000 shares authorized, 21,499 and 21,688 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 215 | 217 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Additional paid-in capital |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated earnings | 1167038 | 1104640 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accumulated other comprehensive loss | (132445) | (128107) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total stockholders' equity | 1034808 | 976750 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total liabilities and stockholders' equity | $5450561 | $5339800 |

---

The following table presents certain assets and liabilities of consolidated variable interest entities ("VIEs") included in the condensed consolidated statements of financial condition above. Most assets in the table below include those assets that can only be used to settle obligations of consolidated VIEs. The liabilities exclude amounts where creditors or beneficial interest holders have recourse to the general credit of the Company. See "Note 8: Variable Interest Entities" for additional information on the Company's VIEs.

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| **Assets** | | |
| Cash and cash equivalents | $50115 | $40256 |
| Receivable portfolios, net | 1177046 | 1151221 |
| Other assets | 4392 | 3540 |
| **Liabilities** |  |  |
| Accounts payable and accrued liabilities | 2986 | 3101 |
| Borrowings | 783444 | 791182 |
| Other liabilities | 1352 | 2774 |

---

*See accompanying notes to condensed consolidated financial statements*

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**Condensed Consolidated Statements of Income**

(In Thousands, Except Per Share Amounts)

(Unaudited)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Revenues |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portfolio revenue | $390019 | $345218 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries | 62740 | 21464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt purchasing revenue | 452759 | 366682 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Servicing revenue | 20638 | 22547 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other revenues | 2014 | 3546 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 475411 | 392775 |
| Operating expenses |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salaries and employee benefits | 114541 | 105932 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of legal collections | 89221 | 68013 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 39629 | 41018 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 34833 | 34252 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collection agency commissions | 6337 | 6873 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6858 | 7344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 291419 | 263432 |
| Income from operations | 183992 | 129343 |
| Other expense |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (73050) | (70530) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income | 790 | 1647 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (72260) | (68883) |
| Income before income taxes | 111732 | 60460 |
| Provision for income taxes | (25489) | (13664) |
| Net income | $86243 | $46796 |
| **Earnings per share:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | $3.97 | $1.96 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | $3.86 | $1.93 |
| Weighted average shares outstanding: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Basic | 21728 | 23879 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Diluted | 22320 | 24269 |

---

*See accompanying notes to condensed consolidated financial statements*

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**Condensed Consolidated Statements of Comprehensive Income**

(Unaudited, In Thousands)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Net income | $86243 | $46796 |
| Other comprehensive (loss) income, net of tax: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in unrealized gain (loss) on derivative instruments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain (loss) on derivative instruments | 10311 | (1065) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax effect | (2287) | 189 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized gain (loss) on derivative instruments, net of tax | 8024 | (876) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Change in foreign currency translation: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized (loss) gain on foreign currency translation | (12233) | 15337 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Income tax effect | (129) | 127 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Unrealized (loss) gain on foreign currency translation, net of tax | (12362) | 15464 |
| Other comprehensive (loss) income, net of tax: | (4338) | 14588 |
| Comprehensive income | $81905 | $61384 |

---

*See accompanying notes to condensed consolidated financial statements*

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**Condensed Consolidated Statements of Equity**

(Unaudited, In Thousands)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Earnings** | **Accumulated Other Comprehensive Loss** | **Total Equity** |
| | **Shares** | **Par** | **Additional Paid-In Capital** | **Accumulated Earnings** | **Accumulated Other Comprehensive Loss** | **Total Equity** |
| **Balance as of December 31, 2025** | 21688 | $217 | $— | $1104640 | $(128107) | $976750 |
| Net income |  |  |  | 86243 |  | 86243 |
| Other comprehensive loss, net of tax |  |  |  |  | (4338) | (4338) |
| Issuance of share-based awards, net of shares withheld for employee taxes | 157 | 1 | (8331) |  |  | (8330) |
| Repurchase and retirement of common stock | (346) | (3) | 3756 | (23845) |  | (20092) |
| Stock-based compensation |  |  | 4575 |  |  | 4575 |
| **Balance as of March 31, 2026** | 21499 | $215 | $— | $1167038 | $(132445) | $1034808 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Common Stock** | **Common Stock** | **Additional Paid-In Capital** | **Accumulated Earnings**  | **Accumulated Other Comprehensive (Loss) Income** | **Total Equity** |
| | **Shares** | **Par** | **Additional Paid-In Capital** | **Accumulated Earnings**  | **Accumulated Other Comprehensive (Loss) Income** | **Total Equity** |
| **Balance as of December 31, 2024** | 23691 | $237 | $19297 | $909927 | $(162130) | $767331 |
| Net income |  |  |  | 46796 |  | 46796 |
| Other comprehensive income, net of tax |  |  |  |  | 14588 | 14588 |
| Issuance of share-based awards, net of shares withheld for employee taxes | 108 | 1 | (3075) |  |  | (3074) |
| Repurchase and retirement of common stock | (289) | (3) | (10001) |  |  | (10004) |
| Stock-based compensation |  |  | 3424 |  |  | 3424 |
| **Balance as of March 31, 2025** | 23510 | $235 | $9645 | $956723 | $(147542) | $819061 |

---

*See accompanying notes to condensed consolidated financial statements*

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**Condensed Consolidated Statements of Cash Flows** 

(Unaudited, In Thousands)

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| **Operating activities:** |  |  |
| Net income | $86243 | $46796 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6858 | 7344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other non-cash interest expense, net | 2537 | 3544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 4575 | 3424 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries | (62740) | (21464) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 4681 | 1737 |
| Changes in operating assets and liabilities |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets | 4892 | (3499) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable, accrued liabilities and other liabilities | 35280 | 7401 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by operating activities | 82326 | 45283 |
| **Investing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of receivable portfolios, net of put-backs | (359463) | (362712) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collections applied to receivable portfolios | 328395 | 259589 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purchases of property and equipment | (4856) | (6990) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | 8517 | 9835 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash used in investing activities | (27407) | (100278) |
| **Financing activities:** |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Payment of loan and debt refinancing costs | (1109) | (255) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Proceeds from credit facilities | 358021 | 246426 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repayment of credit facilities | (304185) | (185831) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase and retirement of common stock | (20092) | (10004) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other, net | (14026) | (9999) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Net cash provided by financing activities | 18609 | 40337 |
| Net increase (decrease) in cash and cash equivalents | 73528 | (14658) |
| Effect of exchange rate changes on cash and cash equivalents | (3108) | 1910 |
| Cash and cash equivalents, beginning of period | 156784 | 199865 |
| Cash and cash equivalents, end of period | $227204 | $187117 |
| Supplemental disclosures of cash flow information: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for interest | $37343 | $41303 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash paid for income taxes, net of refunds | 860 | 1247 |
| Supplemental schedule of non-cash investing activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable portfolios transferred to real estate owned | $1020 | $1040 |

---

&nbsp;&nbsp;&nbsp;&nbsp;

*See accompanying notes to condensed consolidated financial statements*

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**ENCORE CAPITAL GROUP, INC.**

**Notes to Condensed Consolidated Financial Statements (Unaudited)**

**Note 1: Ownership, Description of Business, and Summary of Significant Accounting Policies**

Encore Capital Group, Inc. ("Encore"), through its subsidiaries (collectively with Encore, the "Company"), is an international specialty finance company providing debt recovery solutions and other related services for consumers across a broad range of financial assets. The Company purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals as they repay their obligations and work toward financial recovery. Defaulted receivables are consumers' unpaid financial obligations to credit originators, including banks, credit unions, consumer finance companies and commercial retailers. Defaulted receivables may also include receivables subject to bankruptcy proceedings. The Company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe.

Through Midland Credit Management, Inc. and its domestic affiliates (collectively, "MCM"), the Company is a market leader in portfolio purchasing and recovery in the United States. Through Cabot Credit Management Limited and its subsidiaries and European affiliates (collectively, "Cabot"), the Company is one of the largest credit management services providers in Europe and the United Kingdom. These are the Company's primary operations.

The Company also has investments and operations in Latin America and Asia-Pacific, which the Company refers to as "LAAP."

***Financial Statement Preparation and Presentation***

The accompanying interim condensed consolidated financial statements have been prepared by the Company, without audit, in accordance with the instructions to the Quarterly Report on Form 10-Q, and Rule 10-01 of Regulation S-X promulgated by the United States Securities and Exchange Commission (the "SEC") and, therefore, do not include all information and footnotes necessary for a fair presentation of its condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States ("GAAP").

In the opinion of management, the unaudited financial information for the interim periods presented reflects all adjustments, consisting of only normal and recurring adjustments, necessary for a fair statement of the Company's condensed consolidated financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements included in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025. Operating results for interim periods are not necessarily indicative of operating results for an entire fiscal year.

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts and the disclosure of contingent amounts in the Company's condensed consolidated financial statements and the accompanying notes. Actual results could materially differ from those estimates.

***Basis of Consolidation***

The condensed consolidated financial statements have been prepared in conformity with GAAP and reflect the accounts and operations of the Company and those of its subsidiaries in which the Company has a controlling financial interest. The Company also consolidates variable interest entities ("VIEs") for which it is the primary beneficiary. The primary beneficiary has both (a) the power to direct the activities of the VIE that most significantly affect the entity's economic performance, and (b) either the obligation to absorb losses or the right to receive benefits. Refer to "Note 8: Variable Interest Entities" for further details. All intercompany transactions and balances have been eliminated in consolidation.

***Translation of Foreign Currencies***

The condensed consolidated statements of certain of the Company's foreign subsidiaries are measured using their local currency as the functional currency. Assets and liabilities of foreign operations are translated into U.S. dollars using period-end exchange rates, and revenues and expenses are translated into U.S. dollars using average exchange rates in effect during each period. The resulting translation adjustments are recorded as a component of other comprehensive income or loss. Equity accounts are translated at historical rates, except for the change in retained earnings during the year which is the result of the income statement translation process. Intercompany transaction gains or losses at each period end arising from subsequent measurement of balances for which settlement is not planned or anticipated in the foreseeable future are included as translation adjustments and recorded within other comprehensive income or loss. Translation gains or losses are the material components of accumulated other comprehensive income or loss and are reclassified to earnings upon the substantial sale or liquidation of investments in foreign operations.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Recent Accounting Pronouncements***

In November 2024, the FASB issued ASU 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses ("ASU 2024-03") and in January 2025, the FASB issued ASU 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses: Clarifying the Effective Date ("ASU 2025-01"). ASU 2024-03 requires public business entities to disclose in the notes to the financial statements, among other things, specific information about certain costs and expenses including purchases of inventory; employee compensation; and depreciation, amortization and depletion expenses for each caption on the income statement where such expenses are included. ASU 2024-03, as clarified by ASU 2025-01, is effective for annual periods beginning after December 15, 2026 and interim periods with fiscal years beginning after December 15, 2027. The Company is currently evaluating the impact of this standard on its consolidated financial statements and related disclosures.

In November 2024, the FASB issued ASU 2024-04, Debt - Debt with Conversion and Other Options (Subtopic 470-20): Induced Conversions of Convertible Debt Instruments which clarifies the requirements for determining whether certain settlements of convertible debt instruments should be accounted for as an induced conversion. The new standard is effective for annual periods beginning after December 15, 2025. The Company adopted ASU 2024-04 on a prospective basis as of January 1, 2026. The adoption did not have a material impact on the Company's condensed consolidated financial statements and related disclosures.

In November 2025, the FASB issued ASU 2025-08, Financial Instruments - Credit Losses (Topic 326): Purchased loans. Under ASU 2025-08, loans acquired without credit deterioration and deemed "seasoned" will be considered purchased seasoned loans and accounted for using the gross-up approach at acquisition. The amendments in this update also clarify the recognition and measurement guidance for purchased seasoned loans, including the determination of the initial allowance for credit losses and the subsequent accounting for changes in expected credit losses. The new standard is effective for annual reporting periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the potential impact, but does not expect the adoption of this standard to have a material impact on its consolidated financial statements and related disclosures.

In December 2025, the FASB issued ASU 2025-09, Derivatives and Hedging (Topic 815): Hedge Accounting Improvements. ASU 2025-09 introduces targeted amendments intended to further align hedge accounting with an entity's risk management activities and to simplify the application of certain aspects of the hedge accounting guidance in ASC 815. The new standard is effective for annual periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the potential impact, but does not expect the adoption of this standard to have a material impact on its consolidated financial statements and related disclosures.

**Note 2: Earnings Per Share**

Basic earnings per share is calculated by dividing net income by the weighted average number of shares of common stock outstanding during the period.

The number of shares used to calculate the diluted earnings per share is computed by using the basic weighted-average number of common shares outstanding plus any potentially dilutive common shares outstanding during the period, except when their effect is anti-dilutive. Dilutive potential common shares include outstanding stock based awards, and the dilutive effect of the convertible senior notes, if applicable.

As announced in May 2021, the Company's Board of Directors authorized a $300.0 million share repurchase program. In November 2025, the Company's Board of Directors authorized an increase of an additional $300.0 million under the share repurchase program. During the three months ended March 31, 2026 and 2025, the Company repurchased 345,548 and 289,425 shares of common stock for $20.0 million and $10.0 million, respectively, under the share repurchase program. The Company's practice is to retire the shares repurchased.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

A reconciliation of shares used in calculating earnings per basic and diluted shares follows *(in thousands, except per share amounts)*:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Net income | $86243 | $46796 |
| Shares: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Total weighted-average basic shares outstanding | 21728 | 23879 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dilutive effect of stock-based awards | 592 | 170 |
| &nbsp;&nbsp;&nbsp;&nbsp;Dilutive effect of convertible senior notes |  | 220 |
| Total weighted-average dilutive shares outstanding | 22320 | 24269 |
| Basic earnings per share | $3.97 | $1.96 |
| Diluted earnings per share | $3.86 | $1.93 |

---

**Note 3: Fair Value Measurements**

Fair value is defined as the price that would be received upon sale of an asset or the price paid to transfer a liability, in an orderly transaction between market participants at the measurement date (*i.e.,* the "exit price"). The Company uses a fair value hierarchy that prioritizes the inputs used in valuation techniques to measure fair value into three broad levels. The following is a brief description of each level:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 2: Inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Level 3: Unobservable inputs, including inputs that reflect the reporting entity's own assumptions.

***Financial Instruments Required To Be Carried At Fair Value***

Financial assets and liabilities measured at fair value on a recurring basis are summarized below *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements as of March 31, 2026** | **Fair Value Measurements as of March 31, 2026** | **Fair Value Measurements as of March 31, 2026** | **Fair Value Measurements as of March 31, 2026** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate cap contracts | $— | $1318 | $— | $1318 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreements |  | 224 |  | 224 |
| **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreements |  | (7724) |  | (7724) |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Fair Value Measurements as of December 31, 2025** | **Fair Value Measurements as of December 31, 2025** | **Fair Value Measurements as of December 31, 2025** | **Fair Value Measurements as of December 31, 2025** |
| | **Level 1** | **Level 2** | **Level 3** | **Total** |
| **Assets** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate cap contracts | $— | $286 | $— | $286 |
| **Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreements |  | (16338) |  | (16338) |

---

***Derivative Contracts:***

The Company uses derivative instruments to manage its exposure to fluctuations in interest rates and foreign currency exchange rates. Fair values of these derivative instruments are estimated using models that project future cash flows and discount the future amounts to a present value using market-based observable inputs, including interest rate curves, foreign currency exchange rates, and forward and spot prices for currencies.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Non-Recurring Fair Value Measurement:***

Certain assets are measured at fair value on a nonrecurring basis. Goodwill and property and equipment are adjusted to fair value when an impairment charge is recognized. Such fair values are determined using various valuation techniques under Level 3 fair value hierarchy. REO assets are classified as held for sale at the lower of their carrying value or fair value less cost to sell. The fair value of the assets held for sale and estimated selling expenses were determined at the time of initial recognition and in each reporting period using Level 3 measurements based on appraised values using market comparables. The fair value estimate of the assets held for sale was $14.5 million and $18.1 million as of March 31, 2026 and December 31, 2025, respectively.

***Financial Instruments Not Required To Be Carried At Fair Value***

The table below summarizes fair value estimates for the Company's financial instruments that are not required to be carried at fair value. The total of the fair value calculations presented does not represent, and should not be construed to represent, the underlying value of the Company.

The carrying amounts in the following table are included in the condensed consolidated statements of financial condition as of March 31, 2026 and December 31, 2025 *(in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Fair Value Level** | **Carrying Amount** | **Estimated Fair Value** | **Carrying Amount** | **Estimated Fair Value** |
| **Financial Assets** | | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cash and cash equivalents | Level 1 | $227204 | $227204 | $156784 | $156784 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receivable portfolios, net | Level 3 | 4437415 | 4979583 | 4371532 | 4895167 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other assets<sup>(1)</sup> | Level 2 | 108480 | 108480 | 118130 | 118130 |
| **Financial Liabilities** |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accounts payable and accrued liabilities | Level 2 | 252277 | 252277 | 230261 | 230261 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Global senior secured revolving credit facility | Level 2 | 681267 | 681267 | 631998 | 631998 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior secured notes<sup>(2)</sup> | Level 2 | 2309031 | 2353735 | 2322890 | 2385645 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Convertible senior notes due March 2029 | Level 2 | 230000 | 290529 | 230000 | 253260 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cabot securitisation senior facility | Level 2 | 337253 | 337253 | 343539 | 343539 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;U.S. facility | Level 2 | 450000 | 450000 | 450000 | 450000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other borrowings | Level 2 | 54410 | 54410 | 52926 | 52926 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other liabilities<sup>(1)</sup> | Level 2 | 122451 | 122451 | 115158 | 115158 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Only includes financial instruments not required to be carried at fair value. Derivative instruments, which are required to be carried at fair value are excluded.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Carrying amount represents historical cost, adjusted for any related debt discount.

***Receivable Portfolios:***

The fair value of receivable portfolios is measured by discounting the estimated future cash flows generated by the Company's proprietary forecasting models. The key inputs include the estimated future gross cash flow, average cost to collect, and discount rate. The determination of such inputs requires significant judgment, including assessing the assumed market participant's cost structure, its determination of whether to include fixed costs in its valuation, its collection strategies, and determining the appropriate weighted average cost of capital. The Company evaluates the use of these key inputs on an ongoing basis and refines the data as it continues to obtain better information from market participants in the debt recovery and purchasing business.

***Borrowings:***

The Company's convertible notes and senior secured notes are carried at historical cost, adjusted for the applicable debt discount. The fair value estimate for the convertible notes and the senior secured notes incorporates quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

The carrying values of the Company's senior secured revolving credit facility, securitisation senior facility, U.S. facility, and other borrowings approximate their respective fair values due to the use of current market rates that are repriced frequently.

***Others:***

The carrying values of the Company's cash and cash equivalents, certain other assets, accounts payable and accrued liabilities, and other liabilities approximate their respective fair values due to their short-term nature.

**Note 4: Derivatives and Hedging Instruments**

The Company may periodically enter into derivative financial instruments to manage risks related to interest rates and foreign currency. Certain of the Company's derivative financial instruments qualify for hedge accounting treatment.

The following table summarizes the fair value of derivative instruments as recorded in the Company's condensed consolidated statements of financial condition *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
| | **Balance Sheet Location** | **Fair Value** | **Balance Sheet Location** | **Fair Value** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate cap contracts | Other assets | $1318 | Other assets | $286 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreements | Other assets | 224 |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest rate swap agreements | Other liabilities | (7724) | Other liabilities | (16338) |

---

***Derivatives Designated as Hedging Instruments***

The Company may periodically enter into interest rate swap agreements and interest rate cap contracts to reduce its exposure to fluctuations in interest rates on variable interest rate debt and their impact on earnings and cash flows. Under the swap agreements, the Company receives floating interest rate payments and makes interest payments based on fixed interest rates. Under the cap contracts, the Company receives floating interest rate payments and makes interest payments based on capped interest rates. The Company designates its interest rate swap and interest rate cap instruments as cash flow hedges at inception.

The following tables summarize the terms of the derivative instruments designated as hedging instruments as recorded in the Company's condensed consolidated statements of financial condition:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** | **March 31, 2026** |
| | **Effective date** | **Maturity Date** | **Hedge Designation** | **Notional Amount** | **Receive Floating Rate Index** |
| &nbsp;&nbsp;&nbsp;**Interest rate cap contracts** | &nbsp;&nbsp;&nbsp;**Interest rate cap contracts** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 Cap | September 2024 | September 2026 | Cash flow hedge | $337.3 million | SONIA |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 Cap | September 2026 | January 2028 | Cash flow hedge | $337.3 million | SONIA |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 Cap - U.S. Facility | December 2025 | October 2028 | Cash flow hedge | $130.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;**Interest rate swap agreements** | &nbsp;&nbsp;&nbsp;**Interest rate swap agreements** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2023 Euro IR Swap | October 2023 | January 2028 | Cash flow hedge | $115.6 million | 3-month EURIBOR |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 Euro IR Swaps | June 2024 | January 2028 | Cash flow hedge | $479.6 million | 3-month EURIBOR |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2023 SOFR IR Swaps - U.S. Facility | November 2023 | October 2026 | Cash flow hedge | $150.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 SOFR IR Swaps - U.S. Facility | January 2025 | October 2027 | Cash flow hedge | $125.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 SOFR IR Swaps - Global Senior Facility  | April 2025 | April 2027 | Cash flow hedge | $150.0 million | 1-month SOFR CME Term |

---

In April 2026, the Company entered into a new interest rate cap contract (the "2026 Cap") with a notional amount of £255.0 million (approximately $337.3 million based on an exchange rate of $1.00 to £0.76, the exchange rate as of March 31, 2026). The 2026 Cap is intended to hedge the Company's exposure to fluctuations in interest payments on debt bearing variable interest based on the Sterling Overnight Index Average ("SONIA"). The 2026 Cap has an effective date of January 2028 and a maturity date of January 2029, and will be accounted for as a cash flow hedge.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** | **December 31, 2025** |
| | **Effective date** | **Maturity Date** | **Hedge Designation** | **Notional Amount** | **Receive Floating Rate Index** |
| &nbsp;&nbsp;&nbsp;**Interest rate cap contracts** | &nbsp;&nbsp;&nbsp;**Interest rate cap contracts** | | | | |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 Cap | September 2024 | September 2026 | Cash flow hedge | $343.5 million | SONIA |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 Cap | September 2026 | January 2028 | Cash flow hedge | $343.5 million | SONIA |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 Cap - <br>U.S. Facility | December 2025 | October 2028 | Cash flow hedge | $130.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;**Interest rate swap agreements** | &nbsp;&nbsp;&nbsp;**Interest rate swap agreements** |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2023 Euro IR Swap | October 2023 | January 2028 | Cash flow hedge | $117.5 million | 3-month EURIBOR |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2024 Euro IR Swaps | June 2024 | January 2028 | Cash flow hedge | $487.5 million | 3-month EURIBOR |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2023 SOFR IR Swaps - U.S. Facility | November 2023 | October 2026 | Cash flow hedge | $150.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 SOFR IR Swaps - U.S.Facility | January 2025 | October 2027 | Cash flow hedge | $125.0 million | 1-month SOFR CME Term |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 SOFR IR Swaps - Global Senior Facility | April 2025 | April 2027 | Cash flow hedge | $150.0 million | 1-month SOFR CME Term |

---

The Company expects to reclassify approximately $1.3 million of net derivative loss from OCI into earnings relating to its cash flow designated derivatives within the next 12 months. This amount will vary due to fluctuations in benchmark interest rates.

The following table summarizes the effects of derivatives designated as hedging instruments in the Company's condensed consolidated financial statements *(in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Derivatives Designated as Hedging Instruments** | **Gain (Loss) Recognized in OCI** | **Gain (Loss) Recognized in OCI** | **Location of Loss Reclassified** <br>**from OCI into Income** | **Loss Reclassified** <br>**from OCI** | **Loss Reclassified** <br>**from OCI** |
| **Derivatives Designated as Hedging Instruments** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Location of Loss Reclassified** <br>**from OCI into Income** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| **Derivatives Designated as Hedging Instruments** | **2026** | **2025** | **Location of Loss Reclassified** <br>**from OCI into Income** | **2026** | **2025** |
| Interest rate swap agreements | $6802 | $(1200) | Interest expense | $(2036) | $(467) |
| Interest rate cap contracts | 1033 | (696) | Interest expense | (440) | (364) |

---

**Note 5: Receivable Portfolios, Net**

The Company's purchased portfolios of loans are grossed-up to their face value with an offsetting allowance and noncredit discount allocated to the individual receivables as the unit of account is at the individual loan level. Since each loan is deeply delinquent and deemed uncollectible at the individual loan level, the Company applies its charge-off policy and fully writes-off the amortized costs (*i.e.*, face value net of noncredit discount) of the individual receivables immediately after purchasing the portfolio. The Company then records a negative allowance that represents the present value of all expected future recoveries for pools of receivables that share similar risk characteristics using a discounted cash flow approach, which ultimately equals the amount paid for a portfolio purchase and presented as "Receivable portfolios, net" in the Company's condensed consolidated statements of financial condition. The discount rate is an effective interest rate (or "purchase EIR") based on the purchase price of the portfolio and the expected future cash flows at the time of purchase. The amount of the negative allowance (i.e., receivable portfolios) will not exceed the total amortized cost basis of the loans written-off.

Receivable portfolio purchases are aggregated into pools based on similar risk characteristics. Examples of risk characteristics include financial asset type, collateral type, size, interest rate, date of origination, term, and geographic location. The Company's static pools are typically grouped into credit card, purchased consumer bankruptcy, and mortgage portfolios. The Company further groups these static pools by geographic location. Once a pool is established, the portfolios will remain in the designated pool unless the underlying risk characteristics change. The purchase EIR of a pool will not change over the life of the pool even if expected future cash flows change.

Revenue is recognized for each static pool over the economic life of the pool. Debt purchasing revenue includes two components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) &nbsp;&nbsp;&nbsp;&nbsp;Portfolio revenue, which is the accretion of the discount on the negative allowance due to the passage of time (generally the receivable portfolio balance multiplied by the EIR) and also includes all revenue from zero basis portfolio ("ZBA") collections, and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) &nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries, which includes

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;Recoveries above or below forecast, which is the difference between (i) actual cash collected/recovered during the current period and (ii) expected cash recoveries for the current period, which generally represents over or under performance for the period; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &nbsp;&nbsp;&nbsp;&nbsp;Changes in expected future recoveries, which is the present value change of expected future recoveries, where such change generally results from (i) collections "pulled forward from" or "pushed out to" future periods (i.e. amounts either collected early or expected to be collected later) and (ii) magnitude and timing changes to estimates of expected future collections (which can be increases or decreases).

The Company measures expected future recoveries based on historical experience, current conditions, reasonable and supportable forecasts, and other quantitative and qualitative factors. Factors that may change the expected future recoveries may include both internal as well as external factors. Internal factors include operational performance, such as capacity and the productivity of the Company's collection staff. External factors that may have an impact on the Company's collections include new laws or regulations, new interpretations of existing laws or regulations, and macroeconomic conditions.

Receivable portfolios, net consists of the following as of the dates presented (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **March 31, 2026** | **December 31, 2025** |
| Amortized cost | $— | $— |
| Negative allowance for expected recoveries | 4437415 | 4371532 |
| Balance, end of period | $4437415 | $4371532 |

---

The following table summarizes the changes in the balance of receivable portfolios, net during the periods presented (*in thousands*):

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Balance, beginning of period | $4371532 | $3776369 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Negative allowance for expected recoveries - portfolio purchases<sup>(1)</sup> | 362841 | 367851 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collections applied to receivable portfolios, net<sup>(2)</sup> | (328395) | (259589) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries<sup>(3)</sup> | 62740 | 21464 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Put-backs and recalls | (3378) | (5139) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Disposals and transfers to real estate owned | (1020) | (1040) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Foreign currency translation adjustments | (26905) | 52615 |
| Balance, end of period | $4437415 | $3952531 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)The table below provides the detail on the establishment of negative allowance for expected recoveries of portfolios purchased during the periods presented:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Purchase price | $362841 | $367851 |
| Allowance for credit losses | 951644 | 954659 |
| Amortized cost | 1314485 | 1322510 |
| Noncredit discount | 1755822 | 1659266 |
| Face value | 3070307 | 2981776 |
| Write-off of amortized cost | (1314485) | (1322510) |
| Write-off of noncredit discount | (1755822) | (1659266) |
| Negative allowance | 362841 | 367851 |
| Negative allowance for expected recoveries - portfolio purchases | $362841 | $367851 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(2)Collections applied to receivable portfolios, net, is calculated as follows during the periods presented:

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Cash Collections | $718414 | $604807 |
| Less - amounts classified to portfolio revenue | (390019) | (345218) |
| Collections applied to receivable portfolios, net | $328395 | $259589 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(3)Changes in recoveries is calculated as follows during the periods presented, where recoveries include cash collections, put-backs and recalls, and other cash-based adjustments:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Recoveries above forecast | $46044 | $26952 |
| Changes in expected future recoveries | 16696 | (5488) |
| Changes in recoveries | $62740 | $21464 |

---

Recoveries above or below forecast represent over and under-performance in the reporting period, respectively. Collections during the three months ended March 31, 2026 over-performed the forecasted collections by $46.0 million, primarily driven by collections over-performance in the U.S. resulting from enhanced collections strategies. Collections during the three months ended March 31, 2025 over-performed the forecasted collections by $27.0 million.

Changes in expected future recoveries are reassessed each quarter; the Company considers, among other factors, historical and current collection performance, changes in consumer behavior, and the macroeconomic environment when updating the forecasts of expected lifetime recoveries. The significant recoveries above forecast during the three months ended March 31, 2026 were carefully evaluated. Management concluded that the recoveries above forecast were primarily current period collections over-performance and did not represent any material shift in timing of the collections. Additionally, the sustained over-performance in recent quarters led to increases in forecasted future recoveries for recently acquired vintages. As a result, the Company recorded a net positive change of $16.7 million in expected future recoveries during the three months ended March 31, 2026. During the three months ended March 31, 2025, the Company recorded a net negative change of $5.5 million in expected future recoveries.

**Note 6: Other Assets**

Other assets consist of the following *(in thousands)*:

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Operating lease right-of-use assets | $52645 | $56629 |
| Prepaid expenses | 41137 | 36162 |
| Other financial receivables | 18465 | 21110 |
| Real estate owned | 14496 | 18068 |
| Service fee receivables | 12002 | 13131 |
| Income tax deposits | 6578 | 12959 |
| Deferred tax assets | 4155 | 5766 |
| Other | 27685 | 29288 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $177163 | $193113 |

---

**Note 7: Borrowings**

The Company is in compliance in all material respects with all covenants under its financing arrangements as of March 31, 2026. The components of the Company's consolidated borrowings were as follows *(in thousands)*:

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

---

| | | |
|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** |
| Global senior secured revolving credit facility | $681267 | $631998 |
| Senior secured notes | 2310272 | 2324335 |
| Convertible senior notes | 230000 | 230000 |
| Cabot securitisation senior facility | 337253 | 343539 |
| U.S. facility | 450000 | 450000 |
| Other | 54410 | 52926 |
| Finance lease liabilities | 515 | 596 |
|  | 4063717 | 4033394 |
| Less: debt discount and issuance costs, net of amortization | (30416) | (32101) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $4033301 | $4001293 |

---

Encore is the parent of the restricted group for the Global Senior Facility and the Senior Secured Notes, both of which are guaranteed by the same group of material Encore subsidiaries and secured by the same collateral, which represents substantially all of the assets of those subsidiaries.

***Global Senior Secured Revolving Credit Facility***

In September 2020, the Company entered into a multi-currency senior secured revolving credit facility agreement (as amended and restated, the "Global Senior Facility"). As of March 31, 2026, the Global Senior Facility provided for a total committed facility of $1,485.0 million that matures in September 2029, except for a $69.5 million tranche that terminates in September 2028, and included the following key provisions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Interest at Term SOFR (or EURIBOR for any loan drawn in Euro or a rate based on SONIA for any loan drawn in British Pound), with a Term SOFR (or EURIBOR or SONIA) floor of 0.00%, plus a margin of 2.25%, plus in the case of Term SOFR borrowings, a credit adjustment spread of 0.10%;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An unused commitment fee of 0.40% per annum, payable quarterly in arrears;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A restrictive covenant that limits the LTV Ratio (defined in the Global Senior Facility) to 0.75 in the event that the Global Senior Facility is more than 20% utilized;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A restrictive covenant that limits the SSRCF LTV Ratio (defined in the Global Senior Facility) to 0.275;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• A restrictive covenant that requires the Company to maintain a Fixed Charge Coverage Ratio (as defined in the Global Senior Facility) of at least 2.0;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Additional restrictions and covenants which limit, among other things, the payment of dividends and the incurrence of additional indebtedness and liens; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Standard events of default which, upon occurrence, may permit the lenders to terminate the Global Senior Facility and declare all amounts outstanding to be immediately due and payable.

The Global Senior Facility is secured by substantially all of the assets of the Company and the guarantors. Pursuant to the terms of an intercreditor agreement entered into with respect to the relative positions of (1) the Global Senior Facility and any super priority hedging liabilities (collectively, "Super Senior Liabilities") and (2) the Senior Secured Notes, Super Senior Liabilities that are secured by assets that also secure the Senior Secured Notes will receive priority with respect to any proceeds received upon any enforcement action over any such assets.

As of March 31, 2026, the outstanding borrowings under the Global Senior Facility were $681.3 million. The weighted average interest rate of the Global Senior Facility was 5.53% and 6.56% for the three months ended March 31, 2026 and 2025, respectively. Available capacity under the Global Senior Facility, after taking into account applicable debt covenants, was approximately $791.3 million as of March 31, 2026.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Senior Secured Notes***

The following table provides a summary of the Company's senior secured notes (the "Senior Secured Notes") *($ in thousands)*:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** | **Issue <br>Currency** | **Maturity Date** | **Interest Payment Dates** | **Interest Rate** |
| Encore 2028 Notes | $330640 | $336803 | GBP | Jun 1, 2028 | Jun 1, Dec 1 | 4.250% |
| Encore 2028 Floating Rate Notes  | 479632 | 487532 | EUR | Jan 15, 2028 | Jan 15, Apr 15, Jul 15, Oct 15 | EURIBOR +4.250%<sup>(1)</sup> |
| Encore 2029 Notes | 500000 | 500000 | USD | Apr 1, 2029 | Apr 1, Oct 1 | 9.250% |
| Encore 2030 Notes | 500000 | 500000 | USD | May 15, 2030 | May 15, Nov 15 | 8.500% |
| Encore 2031 Notes | 500000 | 500000 | USD | Apr 15, 2031 | Apr 15, Oct 15 | 6.625% |
|  | $2310272 | $2324335 |  |  |  |  |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Interest rate is based on three-month EURIBOR (subject to a 0% floor) plus 4.250% per annum, resets quarterly.

The Senior Secured Notes are secured by the same collateral as the Global Senior Facility. The guarantees provided in respect of the Senior Secured Notes are pari passu with the guarantee given in respect of the Global Senior Facility. Subject to the intercreditor agreement described above under the section "Global Senior Secured Revolving Credit Facility," Super Senior Liabilities that are secured by assets that also secure the Senior Secured Notes will receive priority with respect to any proceeds received upon any enforcement action over any such assets.

The Encore 2028 Floating Rate Notes had a weighted average interest rate of 6.27% and 7.10% for the three months ended March 31, 2026 and 2025, respectively.

On April 30, 2026, the Company issued a conditional notice of redemption for €200.0 million of the €415.0 million outstanding Encore 2028 Floating Rate Notes at par, with a redemption date of May 28, 2026.

***Convertible Notes***

The following table provides a summary of the principal balance, maturity date and interest rate for the Company's convertible senior notes (the "Convertible Notes") *($ in thousands)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **March 31,<br>2026** | **December 31,<br>2025** | **Maturity Date** | **Interest Payment Dates** | **Interest Rate** |
| 2029 Convertible Notes | $230000 | $230000 | Mar 15, 2029 | Mar 15, Sep 15 | 4.000% |

---

In order to reduce the risk related to the potential dilution and/or the potential cash payments the Company may be required to make in the event that the market price of the Company's common stock becomes greater than the conversion prices of the Convertible Notes, the Company may enter into hedge programs that increase the effective conversion price for the Convertible Notes. In connection with the issuance of the 2029 Convertible Notes, the Company entered into privately negotiated capped call transactions that effectively raised the conversion price of the 2029 Convertible Notes from $65.89 to $82.69. These hedging instruments have been determined to be indexed to the Company's own stock and meet the criteria for equity classification. The Company recorded the cost of the hedge instruments as a reduction in additional paid-in capital, and does not recognize subsequent changes in fair value of these financial instruments in its condensed consolidated financial statements.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

Certain key terms related to the convertible features as of March 31, 2026 are listed below *($ in thousands, except conversion price)*:

---

| | |
|:---|:---|
| | **2029 Convertible Notes** |
| Initial conversion price | $65.89 |
| Closing stock price at date of issuance | $51.68 |
| Closing stock price date | Feb 28, 2023 |
| Initial conversion rate (shares per $1,000 principal amount) | 15.1763 |
| Effective conversion price<sup>(1)</sup> | $82.69 |
| Excess of if-converted value compared to principal<sup>(2)</sup> | $14757 |
| Free conversion date | Dec 15, 2028 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)As discussed above, the Company maintains a hedge program that increases the effective conversion price for the 2029 Convertible Notes to $82.69.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Represents the premium the Company would have to pay assuming the Convertible Notes were converted on March 31, 2026 using a hypothetical share price based on the closing stock price on March 31, 2026.

Prior to the close of business on the business day immediately preceding the free conversion date (listed above), holders may convert their Convertible Notes only under certain circumstances set forth in the indenture. On or after the free conversion date until the close of business on the second scheduled trading day immediately preceding the maturity date, holders may convert their notes at any time.

In the event of conversion, the Convertible Notes are convertible into cash up to the aggregate principal amount of the notes and the excess conversion premium, if any, may be settled in cash or shares of the Company's common stock at the Company's election and subject to certain restrictions contained in each of the indentures governing the Convertible Notes.

The Company's convertible notes are carried as a single liability, which reflects the principal amount of the convertible notes. Interest expense related to the Convertible Notes was $2.3 million and $3.1 million during the three months ended March 31, 2026 and 2025, respectively.

***Cabot Securitisation Senior Facility***

Cabot Securitisation UK Ltd ("Cabot Securitisation"), an indirect subsidiary of Encore, has a senior facility for a committed amount of £255.0 million (as amended, the "Cabot Securitisation Senior Facility"). Prior to March 18, 2026, funds drawn under the Cabot Securitisation Senior Facility bore interest at a rate per annum equal to SONIA plus a margin of 3.20% plus, for periods after January 18, 2028, a step up margin ranging from zero to 1.00%. The Company amended its Cabot Securitisation Senior Facility, effective March 18, 2026, to extend the maturity date from January 2030 to January 2031, and to reduce the margin from 3.20% to 3.00%. For periods after January 18, 2029, a step up margin ranging from zero to 1.00% will apply. The amendment was accounted for as a debt modification.

As of March 31, 2026, the outstanding borrowings under the Cabot Securitisation Senior Facility were £255.0 million (approximately $337.3 million based on an exchange rate of $1.00 to £0.76, the exchange rate as of March 31, 2026). The obligations of Cabot Securitisation under the Cabot Securitisation Senior Facility are secured by first ranking security interests over all of Cabot Securitisation's property, assets and rights (including receivables purchased from Cabot Financial UK from time to time), the book value of which was £277.7 million (approximately $367.3 million based on an exchange rate of $1.00 to £0.76, the exchange rate as of March 31, 2026) as of March 31, 2026. The weighted average interest rate of the Cabot Securitisation Senior Facility was 6.91% and 7.78% for the three months ended March 31, 2026 and 2025, respectively.

Cabot Securitisation is a securitized financing vehicle and is a VIE for consolidation purposes. Refer to "Note 8: Variable Interest Entities" for further details.

***U.S. Facility***

An indirect subsidiary of Encore ("U.S. Financing Subsidiary") has a facility for a committed amount of $450.0 million (as amended, the "U.S. Facility") that matures in October 2028. Funds drawn under the U.S. Facility bear interest at a rate per annum equal to Term SOFR plus a margin of 3.50%.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

As of March 31, 2026, the outstanding borrowings under the U.S. Facility were $450.0 million. The obligations under the U.S. Facility are secured by first ranking security interests over all of U.S. Financing Subsidiary's assets and rights. As of March 31, 2026, this included receivables acquired from MCM, the book value of which was $805.7 million. The weighted average interest rate of the U.S. Facility was 7.18% and 7.82% for the three months ended March 31, 2026 and 2025, respectively.

The U.S. Facility is a securitized financing vehicle and is a VIE for consolidation purposes. Refer to "Note 8: Variable Interest Entities" for further details.

**Note 8: Variable Interest Entities**

A VIE is defined as a legal entity whose equity owners do not have sufficient equity at risk, or, as a group, the holders of the equity investment at risk lack any of the following three characteristics: decision-making rights, the obligation to absorb expected losses, or the right to receive expected residual returns of the entity. The primary beneficiary is identified as the variable interest holder that has both the power to direct the activities of the VIE that most significantly affect the entity's economic performance and the obligation to absorb expected losses or the right to receive residual returns from the entity that could potentially be significant to the VIE. The Company consolidates VIEs when it is the primary beneficiary.

As of March 31, 2026, the Company's VIEs include certain securitized financing vehicles and other immaterial special purpose entities that were created to purchase receivable portfolios in certain geographies. The Company is the primary beneficiary of these VIEs. The Company has the power to direct the activities of the VIEs including the ability to exercise discretion in the servicing of the financial assets and has the right to receive residual returns that could potentially be significant to the VIEs. The Company evaluates its relationships with its VIEs on an ongoing basis to ensure that it continues to be the primary beneficiary.

Most assets recognized as a result of consolidating these VIEs do not represent additional assets that could be used to satisfy claims against the Company's general assets. Conversely, liabilities recognized as a result of consolidating these VIEs do not represent additional claims on the Company's general assets; rather, they represent claims against the specific assets of the VIE.

**Note 10: Income Taxes** 

The Company's effective tax rate was 22.8% and 22.6% for the three months ended March 31, 2026 and 2025, respectively. The differences between the effective tax rate and the federal statutory rate during the periods presented were primarily due to state income taxes offset by other foreign adjustments.

Each interim period is considered an integral part of the annual period and tax expense or benefit is measured using an estimated annual effective income tax rate. The estimated annual effective tax rate for the full year is applied to the respective interim period, taking into account year-to-date amounts and projected amounts for the year. Since the Company operates in foreign countries with varying tax rates, the Company's quarterly effective tax rate is dependent on the level of income or loss from international operations in the reporting period.

The Company's subsidiary in Costa Rica is operating under a 100% tax holiday through April 6, 2034. The impact of the tax holiday in Costa Rica for the three months ended March 31, 2026 and 2025, was immaterial.

The Company is subject to income taxes in the U.S. and foreign jurisdictions. Significant judgment is required in evaluating uncertain tax positions and determining the provision for income taxes.

In December 2021, the Organization for Economic Cooperation and Development ("OECD") enacted model rules for a new global minimum tax framework ("Pillar Two"). Under the Pillar Two rules, a company is required to determine a combined effective tax rate for each jurisdiction. If the jurisdictional effective tax rate determined under the Pillar Two rules is less than 15%, a top-up tax will be due to bring the jurisdictional effective tax rate up to 15%. In December 2022, European Union Member States adopted a directive implementing the Pillar Two rules requiring Member States to enact the directive into their national laws and these began to go into effect from January 1, 2024. The Company has estimated the applicable top-up tax and recorded this in tax expense for the three months ended March 31, 2026. The estimated impact of top-up tax for the three months ended March 31, 2026 was immaterial.

On July 4, 2025, President Trump signed the One Big Beautiful Bill Act ("OBBBA"), which includes a broad range of tax reform provisions affecting businesses. The legislation features permanent extension, with modifications, of key 2017 Tax Cuts and Jobs Act provisions that were set to change at the end of 2025. The effects of the OBBBA were included in the Company's condensed consolidated financial statements for the three months ended March 31, 2026 and the impact was immaterial.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Note 9: Accumulated Other Comprehensive Loss**

A summary of the Company's changes in accumulated other comprehensive loss by component is presented below *(in thousands):* 

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Derivatives** | **Currency Translation Adjustments** | **Accumulated Other Comprehensive Loss** |
| Balance at beginning of period | $(15034) | $(113073) | $(128107) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive income (loss) before reclassification | 7835 | (12233) | (4398) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassification | 2476 |  | 2476 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax effect | (2287) | (129) | (2416) |
| Balance at end of period | $(7010) | $(125435) | $(132445) |

---

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Derivatives** | **Currency Translation Adjustments** | **Accumulated Other Comprehensive Loss** |
| Balance at beginning of period | $(16368) | $(145762) | $(162130) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other comprehensive (loss) income before reclassification | (1896) | 15337 | 13441 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Reclassification | 831 |  | 831 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Tax effect | 189 | 127 | 316 |
| Balance at end of period | $(17244) | $(130298) | $(147542) |

---

**Note 11: Commitments and Contingencies**

***Litigation and Regulatory***

The Company is involved in disputes, legal actions, regulatory investigations, inquiries, and other actions from time to time in the ordinary course of business. The Company, along with others in its industry, is routinely subject to legal actions asserting various claims, including those based on the Fair Debt Collection Practices Act ("FDCPA"), the Fair Credit Reporting Act ("FCRA"), the Telephone Consumer Protection Act ("TCPA"), comparable state statutes, state and federal unfair competition statutes, and common law causes of action. The violations of law investigated or alleged in these actions often include claims that the Company lacks specified licenses to conduct its business, attempts to collect debts on which the statute of limitations has run, has made inaccurate or unsupported assertions of fact in support of its collection actions and/or has acted improperly in connection with its efforts to contact consumers. Such litigation and regulatory actions could involve potential compensatory or punitive damage claims, fines, sanctions, injunctive relief, or changes in business practices. Many continue on for some length of time and involve substantial investigation, litigation, negotiation, and other expense and effort before a result is achieved, and during the process the Company often cannot determine the substance or timing of any eventual outcome.

As of March 31, 2026, there were no material developments in any of the legal proceedings disclosed in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2025 or any new material legal proceedings during the three months ended March 31, 2026.

In certain legal proceedings, the Company may have recourse to insurance or third-party contractual indemnities to cover all or portions of its litigation expenses, judgments, or settlements. The Company records loss contingencies in its financial statements only for matters in which losses are probable and can be reasonably estimated. Where a range of loss can be reasonably estimated with no best estimate in the range, the Company records the minimum estimated liability. The Company continuously assesses the potential liability related to its pending litigation and regulatory matters and revises its estimates when additional information becomes available. The Company's legal costs are recorded to expense as incurred. As of March 31, 2026, the Company has no material reserves for legal matters.

***Purchase Commitments***

In the normal course of business, the Company enters into forward flow purchase agreements. A forward flow purchase agreement is a commitment to purchase receivables over a duration that is typically three to twelve months, but can be longer, generally with a specifically defined volume range, frequency, and pricing. Typically, these forward flow contracts have provisions that allow for early termination or price re-negotiation should the underlying quality of the portfolio deteriorate over time or if any particular month's delivery is materially different than the original portfolio used to price the forward flow

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

contract. Certain of these forward flow purchase agreements may also have termination clauses, whereby the agreements can be canceled by either party upon providing a certain specified amount of notice.

As of March 31, 2026, the Company had entered into forward flow purchase agreements for the purchase of nonperforming loans with an estimated minimum aggregate purchase price of $678.9 million. The Company expects actual purchases under these forward flow purchase agreements to be significantly greater than the estimated minimum aggregate purchase price.

**Note 12: Segment and Geographic Information**

The Company has one reportable segment, debt purchasing and recovery segment. Segment assets are presented in the Company's condensed consolidated statements of financial condition as total assets. The following tables present the results of operations of the Company's reportable segment for the periods presented *(in thousands)*:

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
| | **Debt purchasing and recovery segment** | **Corporate and other unallocated** | **Consolidated** |
| Total revenues | $475411 | $— | $475411 |
| Total operating expenses<sup>(1)</sup> | (276025) | (15394) | (291419) |
| Operating income | 199386 |  | 183992 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other segment items<sup>(2)</sup> |  | 790 | 790 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense<sup>(3)</sup> |  | (73050) | (73050) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes |  | (25489) | (25489) |
| Net income |  |  | $86243 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Certain corporate activities that are not allocated to the debt purchasing and recovery segment are recorded under corporate and other unallocated. During the three months ended March 31, 2026, such non-allocated operating expenses primarily consisted of salaries and employee benefits of $10.3 million for corporate employees and general and administrative expenses of $4.9 million.

&nbsp;&nbsp;&nbsp;&nbsp;(2)The other segment items category includes other income.

&nbsp;&nbsp;&nbsp;&nbsp;(3)The Company manages its available capital resources at the corporate level. Interest expense is not allocated to operating segments.

---

| | | | |
|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** |
| | **Debt purchasing and recovery segment** | **Corporate and other unallocated** | **Consolidated** |
| Total revenues | $392775 | $— | $392775 |
| Total operating expenses<sup>(1)</sup> | (249509) | (13923) | (263432) |
| Operating income | 143266 |  | 129343 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other segment items<sup>(2)</sup> |  | 1647 | 1647 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense<sup>(3)</sup> |  | (70530) | (70530) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes |  | (13664) | (13664) |
| Net income |  |  | $46796 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Certain corporate activities that are not allocated to the debt purchasing and recovery segment are recorded under corporate and other unallocated. During the three months ended March 31, 2025, such non-allocated operating expenses primarily consisted of salaries and employee benefits of $8.1 million for corporate employees and general and administrative expenses of $5.4 million.

&nbsp;&nbsp;&nbsp;&nbsp;(2)The other segment items category includes other income.

&nbsp;&nbsp;&nbsp;&nbsp;(3)The Company manages its available capital resources at the corporate level. Interest expense is not allocated to operating segments.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

The following table presents information about geographic areas in which the Company operates *(in thousands)*:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Total revenues: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United States | $351658 | $269586 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Europe |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;United Kingdom | 88525 | 84468 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other European countries<sup>(1)</sup> | 33437 | 36993 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total Europe | 121962 | 121461 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other geographies<sup>(1)</sup> | 1791 | 1728 |
| Total | $475411 | $392775 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)None of these countries comprise greater than 10% of the Company's consolidated revenues.

**Note 13: Goodwill**

The Company's goodwill is tested for impairment at the reporting unit level annually and in interim periods if certain events occur that indicate that the fair value of a reporting unit may be below its carrying value. Determining the number of reporting units and the fair value of a reporting unit requires the Company to make judgments and involves the use of significant estimates and assumptions.

There have been no events or circumstances during the three months ended March 31, 2026 that have required the Company to perform an interim assessment of goodwill carried at these reporting units. Management continues to evaluate and monitor all key factors impacting the carrying value of the Company's recorded goodwill. Adverse changes in the Company's actual or expected operating results, market capitalization, business climate, economic factors or other negative events that may be outside the control of management could result in a material non-cash impairment charge in the future.

The Company's goodwill is attributable to reporting units included in its portfolio purchasing and recovery segment. The following table summarizes the activity in the Company's goodwill balance *(in thousands)*:

---

| | |
|:---|:---|
| | **Total Company** |
| Balance as of December 31, 2025 | $536291 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effect of foreign currency translation | (6804) |
| Balance as of March 31, 2026 | $529487 |

---

As of March 31, 2026 and December 31, 2025, the Company's accumulated goodwill impairment loss was $338.8 million, attributable to its Cabot reporting unit.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Item 2 – Management's Discussion and Analysis of Financial Condition and Results of Operations**

*This Quarterly Report on Form 10-Q contains "forward-looking statements" relating to Encore Capital Group, Inc. ("Encore") and its subsidiaries (which we may collectively refer to as the "Company," "we," "our" or "us") within the meaning of the securities laws. The words "believe," "expect," "anticipate," "estimate," "project," "intend," "plan," "will," "may," and similar expressions often characterize forward-looking statements. These statements may include, but are not limited to, projections of collections, revenues, income or loss, estimates of capital expenditures, plans for future operations, products or services, and financing needs or plans, as well as assumptions relating to these matters. Although we believe that the expectations reflected in these forward-looking statements are reasonable, we caution that these expectations or predictions may not prove to be correct or we may not achieve the financial results, savings, or other benefits anticipated in the forward-looking statements. These forward-looking statements are necessarily estimates reflecting the best judgment of our senior management and involve a number of risks and uncertainties, some of which may be beyond our control or cannot be predicted or quantified, that could cause actual results to differ materially from those suggested by the forward-looking statements. Many factors including, but not limited to, those set forth in our Annual Report on Form 10-K under "Part I, Item 1A—Risk Factors" could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, achievements or industry results expressed or implied by these forward-looking statements. Our business, financial condition, or results of operations could also be materially and adversely affected by other factors besides those listed. Forward-looking statements speak only as of the date the statements were made. We do not undertake any obligation to update or revise any forward-looking statements to reflect new information or future events, or for any other reason, even if experience or future events make it clear that any expected results expressed or implied by these forward-looking statements will not be realized. In addition, it is generally our policy not to make any specific projections as to future earnings, and we do not endorse projections regarding future performance that may be made by third parties.*

**Our Business** 

We are an international specialty finance company providing debt recovery solutions and other related services for consumers across a broad range of financial assets. We primarily purchase portfolios of defaulted consumer receivables at deep discounts to face value and manage them by working with individuals as they repay their obligations and work toward financial recovery. Defaulted receivables are consumers' unpaid financial obligations to credit originators, including banks, credit unions, consumer finance companies and commercial retailers. Defaulted receivables may also include receivables subject to bankruptcy proceedings. We also provide debt servicing and other portfolio management services to credit originators for non-performing loans in Europe.

Encore Capital Group, Inc. ("Encore") has three business units: MCM, which consists of Midland Credit Management, Inc. and its subsidiaries and domestic affiliates; Cabot, which consists of Cabot Credit Management Limited and its subsidiaries and European affiliates, and LAAP, which is comprised of our investments and operations in Latin America and Asia-Pacific.

***MCM (United States)***

Through MCM, we are a market leader in portfolio purchasing and recovery in the United States.

***Cabot (Europe)***

Through Cabot, we are one of the largest credit management services providers in Europe and the United Kingdom. Cabot, in addition to its primary business of portfolio purchasing and recovery, also provides a range of debt servicing offerings such as early stage collections, business process outsourcing ("BPO"), and contingent collections, including through Wescot Credit Services Limited ("Wescot").

***LAAP (Latin America and Asia-Pacific)***

We have purchased non-performing loans in Mexico. Additionally, we have a subsidiary Encore Asset Reconstruction Company ("EARC") in India.

To date, operating results from LAAP have not been significant to our total consolidated operating results. Our long-term growth strategy is focused on continuing to invest in our core portfolio purchasing and recovery business in the United States and United Kingdom and strengthening and developing our business in France and Spain.

**Government Regulation**

***MCM (United States)***

As discussed in more detail under "Part I - Item 1 - Business - Government Regulation" contained in our Annual Report on Form 10-K, our operations in the United States are subject to federal, state and municipal statutes, rules, regulations and

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

ordinances that establish specific guidelines and procedures that debt purchasers and collectors must follow when collecting consumer accounts, including among others, specific guidelines and procedures for communicating with consumers and prohibitions on unfair, deceptive or abusive debt collection practices.

***Cabot (Europe)***

As discussed in more detail under "Part I - Item 1 - Business - Government Regulation" contained in our Annual Report on Form 10-K, our operations in Europe are affected by foreign statutes, rules and regulations regarding debt collection and debt purchase activities. These statutes, rules, regulations, ordinances, guidelines and procedures are modified from time to time by the relevant authorities charged with their administration, which could affect the way we conduct our business.

**Portfolio Purchasing and Recovery**

***MCM (United States)***

In the United States, the defaulted consumer receivable portfolios we purchase are primarily charged-off credit card debt portfolios. A small percentage of our capital deployment in the United States is comprised of unsecured personal loans.

We purchase receivables based on robust, account-level valuation methods and employ proprietary statistical and behavioral models across our U.S. operations. These methods and models generally allow us to value portfolios accurately (limiting the risk of overpaying), avoid buying portfolios that are incompatible with our methods or strategies and align the accounts we purchase with our business channels to maximize future collections. As a result, we have generally been able to realize significant returns from the receivables we acquire. We maintain strong relationships with many of the largest financial service providers in the United States.

***Cabot (Europe)***

In Europe, our purchased defaulted debt portfolios primarily consist of credit card and consumer loan accounts. We purchase receivable portfolios using proprietary pricing models that utilize account-level statistical and behavioral data. These models generally allow us to accurately value portfolios and to develop collection strategies that maximize future returns. As a result, we have generally been able to realize significant returns from the assets we have acquired. We maintain strong relationships with many of the largest financial services providers in the United Kingdom and Europe.

**Purchases and Collections**

***Portfolio Pricing, Supply and Demand***

***MCM (United States)***

With lending and charge-off rates remaining near recent peak levels, U.S. portfolio supply continues to be robust. Issuers have continued to sell predominantly fresh portfolios. Fresh portfolios are portfolios that are generally sold within six months of the consumer's account being charged-off by the financial institution. Pricing in the first quarter remained at favorable levels as a result of elevated market supply. Issuers continue to sell their volume in mostly forward flow arrangements that are often committed early in the calendar year. We believe steady lending and delinquency rates at elevated levels will result in stable and strong market supply.

We believe that smaller competitors continue to face difficulties in the portfolio purchasing market because of the high cost to operate due to regulatory pressure and increasing cost of capital. We believe this favors larger participants, like MCM, because the larger market participants are better able to adapt to these pressures and commit to larger forward flow agreements and fluctuating volumes.

***Cabot (Europe)***

The UK market for charged-off portfolios generally provides a relatively consistent pipeline of opportunities, despite a historically low level of charge-offs, as creditors have embedded debt sales as an integral part of their business models.

France and Spain continue to be two of the largest non-performing loan markets in Europe with significant portfolio sales. Financial institutions continue to look to dispose of non-performing loans in these markets.

While sales activity across all of our European markets remains stable, underlying default rates are generally low by historic levels, and consumer lending volumes have stagnated. Sales levels are expected to fluctuate from quarter to quarter. In general, portfolio pricing remains competitive across our European footprint, constraining the amount of capital we elect to deploy in Europe.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Purchases by Geographic Location***

The following table summarizes purchases of receivable portfolios by geographic location during the periods presented *(in thousands)*:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| MCM (United States) | $315794 | $316366 |
| Cabot (Europe) | 47047 | 51485 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total purchases of receivable portfolios | $362841 | $367851 |

---

In the United States, capital deployment remained consistent during the three months ended March 31, 2026, as compared to the corresponding period in the prior year. The majority of our deployments in the U.S. come from forward flow agreements, and the timing, contract duration, and volumes for each contract can fluctuate leading to variation when comparing to prior periods. Portfolio purchases in the U.S. were robust as supply increased and pricing remained at favorable levels.

In Europe, capital deployment decreased during the three months ended March 31, 2026, as compared to the corresponding period in the prior year. Pricing continues to remain competitive in our European footprint, constraining the amount of capital we choose to deploy in Europe. Capital deployment can fluctuate based on the timing of the forward flow contracts and spot purchases.

***Collections from Purchased Receivables by Channel and Geographic Location***

We utilize three channels for the collection of our receivable portfolios: call center and digital collections; legal collections; and collection agencies. The call center and digital collections channel consists of collections that result from our call centers, direct mail program and online collections. The legal collections channel consists of collections that result from our internal legal channel or from our network of retained law firms. The collection agencies channel consists of collections from third-party collections agencies to whom we pay a fee or commission. We utilize this channel to supplement capacity in our internal call centers, to service accounts in regions where we do not have collections operations or for accounts purchased where we maintain the collection agency servicing relationship.

The following table summarizes the total collections by collection channel and geographic area during the periods presented *(in thousands)*:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
|  | **2026** | **2025** |
| MCM (United States): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Call center and digital collections | $361457 | $298222 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal collections | 192393 | 151675 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collection agencies | 2621 | 4128 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 556471 | 454025 |
| Cabot (Europe): |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Call center and digital collections | 65292 | 62270 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Legal collections | 57524 | 53773 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collection agencies | 38258 | 33933 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 161074 | 149976 |
| Other geographies: | 869 | 806 |
| Total collections from purchased receivables | $718414 | $604807 |

---

Collections from purchased receivables increased by $113.6 million, or 18.8%, to $718.4 million during the three months ended March 31, 2026, as compared to $604.8 million during the three months ended March 31, 2025. The increase in collections in the United States was primarily a result of consistent increases in capital deployments in the United States in recent periods. Collections in Europe were favorably impacted by foreign currency translation by approximately $12.2 million, during the three months ended March 31, 2026, primarily as a result of the weakening of the U.S. dollar against the British Pound by approximately 6.6% for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Results of Operations**

Results of operations, in dollars and as a percentage of total revenues, were as follows for the periods presented *(in thousands, except percentages)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2026** | **2025** | **2025** |
| Revenues |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Portfolio revenue | $390019 | 82.0% | $345218 | 87.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries | 62740 | 13.2% | 21464 | 5.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total debt purchasing revenue | 452759 | 95.2% | 366682 | 93.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Servicing revenue | 20638 | 4.4% | 22547 | 5.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other revenues | 2014 | 0.4% | 3546 | 0.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | 475411 | 100.0% | 392775 | 100.0% |
| Operating expenses |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Salaries and employee benefits | 114541 | 24.1% | 105932 | 27.0% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cost of legal collections | 89221 | 18.8% | 68013 | 17.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;General and administrative expenses | 39629 | 8.3% | 41018 | 10.4% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other operating expenses | 34833 | 7.4% | 34252 | 8.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Collection agency commissions | 6337 | 1.3% | 6873 | 1.7% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6858 | 1.4% | 7344 | 1.9% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | 291419 | 61.3% | 263432 | 67.1% |
| Income from operations | 183992 | 38.7% | 129343 | 32.9% |
| Other expense |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | (73050) | (15.4)% | (70530) | (18.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Other income | 790 | 0.2% | 1647 | 0.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total other expense | (72260) | (15.2)% | (68883) | (17.5)% |
| Provision for income taxes | (25489) | (5.4)% | (13664) | (3.5)% |
| Net income | $86243 | 18.1% | $46796 | 11.9% |

---

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Comparison of Results of Operations**

**Revenues**

Our revenues primarily include debt purchasing revenue, which is revenue recognized from engaging in debt purchasing and recovery activities. We apply our charge-off policy and fully write-off the amortized costs (*i.e.*, face value net of noncredit discount) of the individual receivables we acquire immediately after purchasing the portfolio. We then record a negative allowance that represents the present value of all expected future recoveries for pools of receivables that share similar risk characteristics using a discounted cash flow approach, which is presented as "Receivable portfolios, net" in our condensed consolidated statements of financial condition. The discount rate is an effective interest rate (or "purchase EIR") established based on the purchase price of the portfolio and the expected future cash flows at the time of purchase.

Debt purchasing revenue includes two components:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) *&nbsp;&nbsp;&nbsp;&nbsp;Portfolio revenue*, which is the accretion of the discount on the negative allowance due to the passage of time (generally the receivable portfolio balance multiplied by the EIR), and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) &nbsp;&nbsp;&nbsp;&nbsp;*Changes in recoveries*, which includes

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;Recoveries above (below) forecast, which is the difference between (i) actual cash collected/recovered during the current period and (ii) expected cash recoveries for the current period, which generally represents over or under performance for the period; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &nbsp;&nbsp;&nbsp;&nbsp;Changes in expected future recoveries, which is the present value change of expected future recoveries, where such change generally results from (i) collections "pulled forward from" or "pushed out to" future periods (i.e. amounts either collected early or expected to be collected later) and (ii) magnitude and timing changes to estimates of expected future collections (which can be increases or decreases).

Certain pools already fully recovered their cost basis and became zero basis portfolios ("ZBA") prior to our adoption of the accounting standard for Financial Instruments - Credit Losses ("CECL") in January 2020. All subsequent collections to the ZBA pools are recognized as ZBA revenue, which is included in portfolio revenue in our condensed consolidated statements of income. We expect our ZBA revenue to continue to decline as we collect on these legacy pools. We do not expect to have new ZBA pools in the future.

Servicing revenue consists primarily of fee-based income earned on accounts collected on behalf of others, primarily credit originators. We earn fee-based income by providing debt servicing (such as early stage collections, BPO, contingent collections, trace services and litigation activities) to credit originators for non-performing loans in Europe.

Other revenues primarily include revenues recognized from the sale of real estate assets that are acquired as a result of our investments in non-performing secured residential mortgage portfolios and real estate assets in Europe and LAAP.

The following tables summarize revenues for the periods presented (*in thousands, except percentages*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** | **% Change** |
| Revenue recognized from portfolio basis | $385593 | $339756 | $45837 | 13.5% |
| ZBA revenue | 4426 | 5462 | (1036) | (19.0)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Portfolio revenue | 390019 | 345218 | 44801 | 13.0% |
| Recoveries above forecast | 46044 | 26952 | 19092 |  |
| Changes in expected future recoveries | 16696 | (5488) | 22184 |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Changes in recoveries | 62740 | 21464 | 41276 | 192.3% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Debt purchasing revenue | 452759 | 366682 | 86077 | 23.5% |
| &nbsp;&nbsp;&nbsp;&nbsp;Servicing revenue | 20638 | 22547 | (1909) | (8.5)% |
| &nbsp;&nbsp;&nbsp;&nbsp;Other revenues | 2014 | 3546 | (1532) | (43.2)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total revenues | $475411 | $392775 | $82636 | 21.0% |

---

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

Our operating results are impacted by foreign currency translation, which represents the effect of translating operating results where the functional currency is different than our U.S. dollar reporting currency. The strengthening of the U.S. dollar relative to other foreign currencies has an unfavorable impact on our international revenues, and the weakening of the U.S. dollar relative to other foreign currencies has a favorable impact on our international revenues. Our revenue was favorably impacted by foreign currency translation by approximately $9.2 million during the three months ended March 31, 2026, primarily as a result of the weakening of the U.S. dollar against the British Pound by approximately 6.6% for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025.

The increase in revenue recognized from portfolio basis during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily due to a higher portfolio basis (i.e. a higher receivable portfolios balance) in the U.S. driven by a consistent higher volume of purchases in recent periods.

Recoveries above or below forecast represent over and under-performance in the reporting period, respectively, and are expected to vary from period to period. Collections during the three months ended March 31, 2026 over-performed the forecasted collections by $46.0 million, primarily as a result of collections over-performance in the U.S. The collections over-performance in the U.S. was driven by the deployment of new technologies, enhanced digital capabilities and continued operational innovation, which enabled us to reach more consumers, leading to more payments as well as a larger payer book. These initiatives had a greater impact on the early stages of a portfolio's lifecycle, leading to over-performance for our recent vintages. Collections during the three months ended March 31, 2025 over-performed the forecasted collections by $27.0 million.

We reassess the forecasts of expected lifetime recoveries each quarter by considering, among other factors, historical and current collection performance, changes in consumer behaviors, and the macroeconomic environment. The significant recoveries above forecast during the three months ended March 31, 2026 were carefully evaluated. We concluded that the recoveries above forecast during the three months ended March 31, 2026 were primarily current period collections over-performance and did not represent any material shift in timing of the collections. Additionally, the sustained over-performance in recent quarters led to increases in forecasted future recoveries for recently acquired vintages. As a result, we recorded a net positive change of $16.7 million in expected future recoveries during the three months ended March 31, 2026. During the three months ended March 31, 2025, we recorded a net negative change of $5.5 million in expected future recoveries.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

The following tables summarize collections from receivable portfolios, portfolio revenue, changes in recoveries, end of period receivable portfolios balance and other related supplemental data, by year of purchase (*in thousands, except percentages*):

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
| | **Collections** | **Portfolio Revenue** | **Changes in Recoveries** | **Receivable Portfolios** | **Monthly EIR** |
| **United States:** | | | | | |
| ZBA | $4425 | $4425 | $— | $— | —% |
| <2022 | 77574 | 46288 | (2242) | 305922 | 4.7% |
| 2022 | 33804 | 15529 | (36) | 155539 | 3.1% |
| 2023 | 87476 | 38426 | 15474 | 373329 | 3.3% |
| 2024 | 163194 | 73510 | 15210 | 688135 | 3.3% |
| 2025 | 180168 | 107292 | 24369 | 1077429 | 3.2% |
| 2026 | 9830 | 10781 | 2632 | 319246 | 3.4% |
| &nbsp;&nbsp;&nbsp;Subtotal | 556471 | 296251 | 55407 | 2919600 | 3.4% |
| **Europe:** |  |  |  |  |  |
| ZBA | 1 | 1 |  |  | —% |
| <2022 | 75611 | 49761 | (691) | 691916 | 2.3% |
| 2022 | 11474 | 5993 | (469) | 123745 | 1.5% |
| 2023 | 17247 | 7595 | 3988 | 167117 | 1.5% |
| 2024 | 31165 | 16290 | 1249 | 273420 | 1.9% |
| 2025 | 23794 | 13225 | 1724 | 203815 | 2.1% |
| 2026 | 1782 | 903 | 1065 | 46247 | 2.1% |
| &nbsp;&nbsp;&nbsp;Subtotal | 161074 | 93768 | 6866 | 1506260 | 2.0% |
| **Other geographies**<sup>(1)</sup>**:** |  |  |  |  |  |
| All vintages | 869 |  | 467 | 11555 | —% |
| &nbsp;&nbsp;&nbsp;Subtotal | 869 |  | 467 | 11555 | —% |
| &nbsp;&nbsp;&nbsp;Total | $718414 | $390019 | $62740 | $4437415 | 2.9% |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)All portfolios are on non-accrual basis. Annual pool groups for other geographies have been aggregated for disclosure purposes.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **Three Months Ended March 31, 2025** | **As of March 31, 2025** | **As of March 31, 2025** |
|  | **Collections** | **Portfolio Revenue** | **Changes in Recoveries** | **Receivable Portfolios** | **Monthly EIR** |
| **United States:** |  |  |  |  |  |
| ZBA | $5461 | $5461 | $— | $— | —% |
| <2021 | 90900 | 53386 | (648) | 343830 | 4.8% |
| 2021 | 25222 | 13647 | (367) | 107762 | 3.9% |
| 2022 | 52950 | 23399 | 1478 | 234231 | 3.1% |
| 2023 | 116222 | 57733 | (3447) | 548323 | 3.3% |
| 2024 | 153494 | 94002 | 11370 | 904359 | 3.3% |
| 2025 | 9776 | 10072 | 3500 | 320049 | 3.1% |
| &nbsp;&nbsp;&nbsp;Subtotal | 454025 | 257700 | 11886 | 2458554 | 3.5% |
| **Europe:** |  |  |  |  |  |
| ZBA | 1 | 1 |  |  | —% |
| <2021 | 71905 | 46341 | 4478 | 663794 | 2.3% |
| 2021 | 10468 | 6512 | 58 | 117260 | 1.9% |
| 2022 | 13936 | 6575 | 890 | 141172 | 1.5% |
| 2023 | 20790 | 8165 | 2124 | 183208 | 1.5% |
| 2024 | 30395 | 18388 | 1080 | 320444 | 1.9% |
| 2025 | 2481 | 1536 | 470 | 52352 | 2.3% |
| &nbsp;&nbsp;&nbsp;Subtotal | 149976 | 87518 | 9100 | 1478230 | 2.0% |
| **Other geographies**<sup>(1)</sup>**:** |  |  |  |  |  |
| All vintages | 806 |  | 478 | 15747 | —% |
| &nbsp;&nbsp;&nbsp;Subtotal | 806 |  | 478 | 15747 | —% |
| &nbsp;&nbsp;&nbsp;Total | $604807 | $345218 | $21464 | $3952531 | 2.9% |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)All portfolios are on non-accrual basis. Annual pool groups for other geographies have been aggregated for disclosure purposes.

Servicing revenue decreased during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, primarily driven by decreases in BPO revenue and collection service fees. Other revenues decreased during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, primarily driven by a decrease in gains recognized on the sale of real estate assets.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Operating Expenses**

The following table summarizes operating expenses during the periods presented (*in thousands, except percentages*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** | **% Change** |
| Salaries and employee benefits | $114541 | $105932 | $8609 | 8.1% |
| Cost of legal collections | 89221 | 68013 | 21208 | 31.2% |
| General and administrative expenses | 39629 | 41018 | (1389) | (3.4)% |
| Other operating expenses | 34833 | 34252 | 581 | 1.7% |
| Collection agency commissions | 6337 | 6873 | (536) | (7.8)% |
| Depreciation and amortization | 6858 | 7344 | (486) | (6.6)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total operating expenses | $291419 | $263432 | $27987 | 10.6% |

---

Our operating results are impacted by foreign currency translation, which represents the effect of translating operating results where the functional currency is different than our U.S. dollar reporting currency. The strengthening of the U.S. dollar relative to other foreign currencies has a favorable impact on our international operating expenses, and the weakening of the U.S. dollar relative to other foreign currencies has an unfavorable impact on our international operating expenses. Our operating expenses were unfavorably impacted by foreign currency translation by approximately $6.6 million, during the three months ended March 31, 2026, primarily as a result of the weakening of the U.S. dollar against the British Pound by approximately 6.6% for the three months ended March 31, 2026, as compared to the three months ended March 31, 2025.

Operating expenses are explained in more detail as follows:

***Salaries and Employee Benefits***

The increase in salaries and employee benefits during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily due to the following reasons:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An increase in salaries and bonuses of $6.2 million, primarily attributable to higher performance-based bonuses awarded to employees as a result of our strong overall performance for the year ended December 31, 2025; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• An increase in stock-based compensation expense of $1.2 million attributable to increased stock price in the recent periods and higher vesting of performance-based awards.

***Cost of Legal Collections***

Cost of legal collections primarily includes contingent fees paid to our external network of attorneys and the cost of litigation. We pursue legal collections using a network of attorneys that specialize in collection matters and through our internal legal channel. Under the agreements with our contracted attorneys, we advance certain out-of-pocket court costs. Cost of legal collections does not include internal legal channel employee costs, which are included in salaries and employee benefits in our condensed consolidated statements of income.

The following table summarizes our cost of legal collections during the periods presented (*in thousands, except percentages*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** | **% Change** |
| Court costs | $60967 | $44814 | $16153 | 36.0% |
| Legal collection fees | 28254 | 23199 | 5055 | 21.8% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total cost of legal collections | $89221 | $68013 | $21208 | 31.2% |

---

The increase of cost of legal collections during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily due to increased legal placements in this channel in the United States.

***General and Administrative Expenses***

The decrease in general and administrative expense during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily attributable to a decrease in consulting and audit fees of $1.9 million. The decrease was partially offset by an increase in information technology expenses of $1.1 million.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Other Operating Expenses***

Other operating expenses remained relatively consistent during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025.

***Collection Agency Commissions***

Collection agency commissions are commissions paid to third-party collection agencies. Collections through the collections agencies channel are predominately in Europe and vary from period to period depending on, among other things, the number of accounts placed with an agency versus accounts collected internally. Commission rates vary depending on, among other things, the amount of time that has passed since the charge-off of the accounts placed with an agency, the asset class, and the geographic location of the receivables. Generally, freshly charged-off accounts have a lower commission rate than accounts that have been charged off for a longer period of time, and commission rates for purchased bankruptcy portfolios are lower than the commission rates for charged-off credit card accounts. Collection agency commissions slightly decreased during the three months ended March 31, 2026, as compared to the same period in the prior year, due to fewer accounts placed with external agencies in the United States.

***Depreciation and Amortization***

Depreciation and amortization expenses decreased by $0.5 million during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025. The decrease was primarily due to smaller depreciable and amortizable asset balances during the three months ended March 31, 2026, as compared to the corresponding period in the prior year.

**Interest Expense**

The following table summarizes our interest expense for the periods presented (*in thousands, except percentages)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** | **$ Change** | **% Change** |
| Stated interest on debt obligations | $70513 | $66986 | $3527 | 5.3% |
| Amortization of debt issuance costs | 2355 | 3329 | (974) | (29.3)% |
| Amortization of debt discount | 182 | 215 | (33) | (15.3)% |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total interest expense | $73050 | $70530 | $2520 | 3.6% |

---

The increase in interest expense during the three months ended March 31, 2026, as compared to the three months ended March 31, 2025, was primarily due to the following reasons:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect resulting from increased average debt balance of approximately $4.0 million; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The effect resulting from an unfavorable impact of foreign currency translation of approximately $1.7 million driven by the weakening of the U.S. dollar against the British Pound.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• The increase was partially offset by the effect resulting from a decrease in interest rates of approximately $3.2 million..

**Other Income, net of Other Expense**

Other income or expense consists primarily of foreign currency exchange gains or losses, interest income, and gains or losses recognized on certain transactions outside of our normal course of business. Other income, net, was $0.8 million and $1.6 million during the three months ended March 31, 2026 and 2025, respectively. Interest income included in other income, net of other expense, was $1.1 million and $1.5 million during the three months ended March 31, 2026 and 2025, respectively.

**Provision for Income Taxes** 

Provision for income taxes and effective tax rate are as follows for the periods presented (*$ in thousands*):

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2026** | **2025** | **2025** |
| Provision for income taxes | $| 25489 | $| 13664 |
| Effective tax rate | 22.8% | 22.8% | 22.6% | 22.6% |

---

For the three months ended March 31, 2026 and 2025, the differences between our effective tax rate and the federal statutory rate were primarily due to state income taxes offset by other foreign adjustments.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Non-GAAP Disclosure**

In addition to the financial information prepared in conformity with Generally Accepted Accounting Principles ("GAAP"), we provide historical non-GAAP financial information. Management believes that the presentation of such non-GAAP financial information is meaningful and useful in understanding the activities and business metrics of our operations. Management believes that these non-GAAP financial measures reflect an additional way of viewing aspects of our business that, when viewed with our GAAP results, provide a more complete understanding of factors and trends affecting our business.

Management believes that the presentation of these measures provides investors with greater transparency and facilitates comparison of operating results across a broad spectrum of companies with varying capital structures, compensation strategies, derivative instruments, and amortization methods, which provide a more complete understanding of our financial performance, competitive position, and prospects for the future. Readers should consider the information in addition to, but not instead of, our financial statements prepared in accordance with GAAP. This non-GAAP financial information may be determined or calculated differently by other companies, limiting the usefulness of these measures for comparative purposes.

***Adjusted EBITDA.*** Management utilizes adjusted EBITDA (defined as net income before interest income and expense, taxes, depreciation and amortization, stock-based compensation expenses, acquisition, integration and restructuring related expenses, and other charges or gains that are not indicative of ongoing operations), in the evaluation of our operating performance. Adjusted EBITDA for the periods presented is as follows *(in thousands)*:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| GAAP net income, as reported | $86243 | $46796 |
| Adjustments: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest expense | 73050 | 70530 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Interest income | (1094) | (1546) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Provision for income taxes | 25489 | 13664 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Depreciation and amortization | 6858 | 7344 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock-based compensation expense | 4575 | 3424 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Acquisition, integration and restructuring related expenses<sup>(1)</sup> | 1465 | 248 |
| Adjusted EBITDA | $196586 | $140460 |
| Collections applied to principal balance<sup>(2)</sup> | $269469 | $244300 |

---

_______________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Amount represents acquisition, integration and restructuring related expenses. We adjust for this amount because we believe these expenses are not indicative of ongoing operations; therefore, adjusting for these expenses enhances comparability to prior periods, anticipated future periods, and our competitors' results.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Collections applied to principal balance is calculated in the table below:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended<br>March 31,** | **Three Months Ended<br>March 31,** |
| | **2026** | **2025** |
| Collections applied to receivable portfolios, net | $328395 | $259589 |
| Changes in recoveries | (62740) | (21464) |
| Other proceeds applied to basis | 3814 | 6175 |
| Collections applied to principal balance | $269469 | $244300 |

---

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Supplemental Performance Data**

The tables included in this supplemental performance data section include detail for purchases, collections and ERC by year of purchase.

Our collection expectations are based on account characteristics and economic variables. Additional adjustments are made to account for qualitative factors that may affect the payment behavior of our consumers and servicing related adjustments to ensure our collection expectations are aligned with our operations. We continue to refine our process of forecasting collections both domestically and internationally with a focus on operational enhancements. Our collection expectations vary between types of portfolio and geographic location. As a result, past performance of pools in certain geographic locations or of certain types of portfolio are not necessarily a suitable indicator of future results in other locations or for other types of portfolio.

The supplemental performance data presented in this section is impacted by foreign currency translation, which represents the effect of translating financial results where the functional currency of our foreign subsidiary is different than our U.S. dollar reporting currency. Generally, international purchases reflect the exchange rates at the time of purchase and international cumulative collections are aggregated each month based on respective month-end exchange rates. For example, the strengthening of the U.S. dollar relative to other foreign currencies has an unfavorable reporting impact on our international purchases, collections, and ERC, and the weakening of the U.S. dollar relative to other foreign currencies has a favorable impact on our international purchases, collections, and ERC.

We utilize proprietary forecasting models to continuously evaluate the economic life of each pool.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Cumulative Collections Money Multiple - Cumulative Collections from Receivable Portfolios to Purchase Price Multiple***

The following table summarizes our receivable purchases, related collections, and cumulative collections money multiples *(in thousands, except multiples)*:

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Year of<br>Purchase** | **Purchase**<br>**Price**<sup>(1)</sup> | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** | **Cumulative Collections through March 31, 2026** |
| **Year of<br>Purchase** | **Purchase**<br>**Price**<sup>(1)</sup> | **<2022** | **2022** | **2023** | **2024** | **2025** | **2026** | **Total**<sup>(2)</sup> | **CCMM**<sup>(3)</sup> |
| *United States*: | *United States*: | *United States*: | *United States*: | *United States*: | *United States*: | *United States*: | *United States*: | *United States*: | *United States*: |
| <2022 | $7585852 | $16334075 | $1256655 | $861884 | $606852 | $432143 | $81999 | $19573608 | 2.6 |
| 2022 | 548765 |  | 98277 | 268516 | 254329 | 179247 | 33804 | 834173 | 1.5 |
| 2023 | 805587 |  |  | 184182 | 471838 | 419265 | 87476 | 1162761 | 1.4 |
| 2024 | 990595 |  |  |  | 238635 | 625051 | 163194 | 1026880 | 1.0 |
| 2025 | 1168557 |  |  |  |  | 293593 | 180168 | 473761 | 0.4 |
| 2026 | 315662 |  |  |  |  |  | 9830 | 9830 |  |
| &nbsp;&nbsp;&nbsp;Subtotal | 11415018 | 16334075 | 1354932 | 1314582 | 1571654 | 1949299 | 556471 | 23081013 | 2.0 |
| *Europe*: |  |  |  |  |  |  |  |  |  |
| <2022 | 3421004 | 4512881 | 516314 | 432671 | 383208 | 336631 | 75611 | 6257316 | 1.8 |
| 2022 | 231869 |  | 36957 | 70385 | 64555 | 52865 | 11474 | 236236 | 1.0 |
| 2023 | 259255 |  |  | 40975 | 89799 | 78352 | 17247 | 226373 | 0.9 |
| 2024 | 353182 |  |  |  | 50469 | 128970 | 31165 | 210604 | 0.6 |
| 2025 | 234058 |  |  |  |  | 44123 | 23794 | 67917 | 0.3 |
| 2026 | 47047 |  |  |  |  |  | 1783 | 1783 |  |
| &nbsp;&nbsp;&nbsp;Subtotal | 4546415 | 4512881 | 553271 | 544031 | 588031 | 640941 | 161074 | 7000229 | 1.5 |
| *Other geographies*<sup>(4)</sup>: | *Other geographies*<sup>(4)</sup>: |  |  |  |  |  |  |  |  |
| All vintages | 340283 | 538948 | 3334 | 3954 | 2793 | 2546 | 869 | 552444 | 1.6 |
| &nbsp;&nbsp;&nbsp;Subtotal | 340283 | 538948 | 3334 | 3954 | 2793 | 2546 | 869 | 552444 | 1.6 |
| &nbsp;&nbsp;&nbsp;Total | $16301716 | $21385904 | $1911537 | $1862567 | $2162478 | $2592786 | $718414 | $30633686 | 1.9 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Adjusted for Put-Backs and Recalls. Put-Backs ("Put-Backs") and recalls ("Recalls") represent ineligible accounts that are returned by us or recalled by the seller pursuant to specific guidelines as set forth in the respective purchase agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Cumulative collections from inception through March 31, 2026, excluding collections on behalf of others.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Cumulative Collections Money Multiple ("CCMM") through March 31, 2026 refers to cumulative collections as a multiple of purchase price.

&nbsp;&nbsp;&nbsp;&nbsp;(4)Annual pool groups for other geographies have been aggregated for disclosure purposes.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Purchase Price Multiple - Total Estimated Collections from Receivable Portfolios to Purchase Price Multiple***

The following table summarizes our purchases, resulting historical collections, estimated remaining collections from receivable portfolios, and purchase price multiple *(in thousands, except multiples)*:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | **Purchase Price**<sup>(1)</sup> | **Historical**<br>**Collections**<sup>(2)</sup> | **Estimated <br>Remaining <br>Collections** | **Total Estimated**<br>**Collections** | **Purchase Price Multiple**<sup>(3)</sup> |
| *United States*: |  |  |  |  |  |
| <2022 | $7585852 | $19573608 | $773935 | $20347543 | 2.7 |
| 2022 | 548765 | 834173 | 314437 | 1148610 | 2.1 |
| 2023 | 805587 | 1162761 | 774834 | 1937595 | 2.4 |
| 2024 | 990595 | 1026880 | 1408010 | 2434890 | 2.5 |
| 2025 | 1168557 | 473761 | 2287290 | 2761051 | 2.4 |
| 2026 | 315662 | 9830 | 737504 | 747334 | 2.4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 11415018 | 23081013 | 6296010 | 29377023 | 2.6 |
| *Europe*: |  |  |  |  |  |
| <2022 | 3421004 | 6257316 | 1824997 | 8082313 | 2.4 |
| 2022 | 231869 | 236236 | 227062 | 463298 | 2.0 |
| 2023 | 259255 | 226373 | 298192 | 524565 | 2.0 |
| 2024 | 353182 | 210604 | 591577 | 802181 | 2.3 |
| 2025 | 234058 | 67917 | 453466 | 521383 | 2.2 |
| 2026 | 47047 | 1783 | 100011 | 101794 | 2.2 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 4546415 | 7000229 | 3495305 | 10495534 | 2.3 |
| *Other geographies*<sup>(4)</sup>: | *Other geographies*<sup>(4)</sup>: |  |  |  |  |
| All vintages | 340283 | 552444 | 15188 | 567632 | 1.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subtotal | 340283 | 552444 | 15188 | 567632 | 1.7 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $16301716 | $30633686 | $9806503 | $40440189 | 2.5 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Purchase price refers to the cash paid to a seller to acquire a portfolio less Put-backs, Recalls, and other adjustments. Put-Backs and Recalls represent ineligible accounts that are returned by us or recalled by the seller pursuant to specific guidelines as set forth in the respective purchase agreement.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Cumulative collections from inception through March 31, 2026, excluding collections on behalf of others.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Purchase Price Multiple represents total estimated collections divided by the purchase price.

&nbsp;&nbsp;&nbsp;&nbsp;(4)Annual pool groups for other geographies have been aggregated for disclosure purposes.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Estimated Remaining Collections by Year of Purchase***

The following table summarizes our estimated remaining collections from receivable portfolios and estimated future cash flows from real estate-owned assets *(in thousands)*:

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> | **Estimated Remaining Collections by Year of Purchase**<sup>(1)</sup> |
| | **2026**<sup>(3)</sup> | **2027** | **2028** | **2029** | **2030** | **2031** | **2032** | **2033** | **2034** | **>2034** | **Total**<sup>(2)</sup> |
| *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* | *United States:* |
| <2022 | $200422 | $184823 | $125010 | $85051 | $58019 | $39781 | $27417 | $18716 | $12721 | $21975 | $773935 |
| 2022 | 75537 | 74349 | 49788 | 34372 | 24460 | 17364 | 12089 | 8374 | 5894 | 12210 | 314437 |
| 2023 | 186065 | 182174 | 126702 | 84762 | 58724 | 41723 | 29662 | 20589 | 14323 | 30110 | 774834 |
| 2024 | 369136 | 323639 | 214981 | 151775 | 106721 | 75768 | 53083 | 37068 | 25697 | 50142 | 1408010 |
| 2025 | 474817 | 585490 | 371868 | 253617 | 181467 | 128405 | 91325 | 63968 | 44694 | 91639 | 2287290 |
| 2026 | 129302 | 180457 | 136036 | 87385 | 60934 | 43221 | 30674 | 21772 | 15232 | 32491 | 737504 |
| &nbsp;&nbsp;&nbsp;Subtotal | 1435279 | 1530932 | 1024385 | 696962 | 490325 | 346262 | 244250 | 170487 | 118561 | 238567 | 6296010 |
| *Europe:* |  |  |  |  |  |  |  |  |  |  |  |
| <2022 | 208102 | 246871 | 213789 | 182450 | 155598 | 134031 | 117071 | 103112 | 91022 | 372951 | 1824997 |
| 2022 | 33276 | 38336 | 30505 | 24841 | 20312 | 16735 | 13696 | 10987 | 9075 | 29299 | 227062 |
| 2023 | 44652 | 49643 | 41465 | 33310 | 26542 | 21374 | 17553 | 14389 | 11700 | 37564 | 298192 |
| 2024 | 76061 | 87434 | 73802 | 61372 | 50910 | 42297 | 35841 | 31129 | 27071 | 105660 | 591577 |
| 2025 | 60518 | 72436 | 59043 | 48245 | 39282 | 32082 | 26525 | 22654 | 19209 | 73472 | 453466 |
| 2026 | 12528 | 17040 | 14567 | 11567 | 9264 | 7372 | 5917 | 4805 | 3892 | 13059 | 100011 |
| &nbsp;&nbsp;&nbsp;Subtotal | 435137 | 511760 | 433171 | 361785 | 301908 | 253891 | 216603 | 187076 | 161969 | 632005 | 3495305 |
| *Other geographies*<sup>(4)</sup>: | *Other geographies*<sup>(4)</sup>: |  |  |  |  |  |  |  |  |  |  |
| All vintages |  |  |  |  |  |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Subtotal | 4791 | 4117 | 2662 | 1734 | 890 | 471 | 244 | 144 | 75 | 60 | 15188 |
| &nbsp;&nbsp;&nbsp;Portfolio ERC | 1875207 | 2046809 | 1460218 | 1060481 | 793123 | 600624 | 461097 | 357707 | 280605 | 870632 | 9806503 |
| &nbsp;&nbsp;REO ERC<sup>(5)</sup> | 14503 | 4260 |  |  |  |  |  |  |  |  | 18763 |
| &nbsp;&nbsp;&nbsp;Total ERC | $1889710 | $2051069 | $1460218 | $1060481 | $793123 | $600624 | $461097 | $357707 | $280605 | $870632 | $9825266 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)As of March 31, 2026, ERC for Zero Basis Portfolios includes $22.9 million for purchased consumer and bankruptcy receivables in the United States. ERC for Zero Basis Portfolios in Europe and other geographies was immaterial. ERC also includes $15.2 million from non-accrual portfolios, primarily in other geographies.

&nbsp;&nbsp;&nbsp;&nbsp;(2)Represents the expected remaining cash collections over a 180-month period. As of March 31, 2026, ERC for 84-months was $8,414.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;(3)Amount for 2026 consists of nine months data from April 1, 2026 to December 31, 2026.

&nbsp;&nbsp;&nbsp;&nbsp;(4)Annual pool groups for other geographies have been aggregated for disclosure purposes.

&nbsp;&nbsp;&nbsp;&nbsp;(5)Real estate-owned assets ("REO") ERC includes $18.8 million of estimated future cash flows for Europe.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

***Estimated Future Collections Applied to Receivable Portfolios***

As of March 31, 2026, we had $4.4 billion in receivable portfolios. The estimated future collections applied to the receivable portfolios net balance is as follows *(in thousands)*:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Years Ending December 31,** | **United States** | **Europe** | **Other Geographies** | **Total Amortization** |
| 2026<sup>(1)</sup> | $621183 | $174650 | $3953 | $799786 |
| 2027 | 734526 | 210976 | 3203 | 948705 |
| 2028 | 482365 | 179622 | 1946 | 663933 |
| 2029 | 319267 | 148100 | 1192 | 468559 |
| 2030 | 224370 | 120752 | 510 | 345632 |
| 2031 | 159558 | 99178 | 341 | 259077 |
| 2032 | 113876 | 83890 | 186 | 197952 |
| 2033 | 80275 | 73286 | 113 | 153674 |
| 2034 | 56067 | 64961 | 60 | 121088 |
| 2035 | 39742 | 60947 | 32 | 100721 |
| 2036 | 29255 | 57113 | 15 | 86383 |
| 2037 | 21760 | 54476 | 4 | 76240 |
| 2038 | 17217 | 55648 |  | 72865 |
| 2039 | 12816 | 56411 |  | 69227 |
| 2040 | 6656 | 52260 |  | 58916 |
| 2041 | 667 | 13990 |  | 14657 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | $2919600 | $1506260 | $11555 | $4437415 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)Amount for 2026 consists of nine months data from April 1, 2026 to December 31, 2026.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Liquidity and Capital Resources**

***Liquidity***

The following table summarizes our cash flow activities for the periods presented *(in thousands)*:

---

| | | |
|:---|:---|:---|
| | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
| | **2026** | **2025** |
| | (Unaudited) | (Unaudited) |
| Net cash provided by operating activities | $82326 | $45283 |
| Net cash used in investing activities | (27407) | (100278) |
| Net cash provided by financing activities | 18609 | 40337 |

---

***Operating Cash Flows***

Cash flows from operating activities represent the cash receipts and disbursements related to all of our activities other than investing and financing activities.

Net cash provided by operating activities was $82.3 million and $45.3 million during the three months ended March 31, 2026 and 2025, respectively. Operating cash flows are derived by adjusting net income for non-cash operating items such as depreciation and amortization, changes in recoveries, stock-based compensation charges, deferred income tax, and changes in operating assets and liabilities which reflect timing differences between the receipt and payment of cash associated with transactions and when they are recognized in results of operations. Adjusting for the changes in recoveries resulted in a decrease in operating cash flows by $62.7 million during the three months ended March 31, 2026 and a decrease in operating cash flows by $21.5 million during the three months ended March 31, 2025. Refer to "Note 5: Receivable Portfolios, Net" in the notes to our condensed consolidated financial statements for discussion relating to changes in recoveries.

***Investing Cash Flows*** 

Net cash used in investing activities was $27.4 million and $100.3 million during the three months ended March 31, 2026 and 2025, respectively. Cash provided by or used in investing activities is primarily affected by receivable portfolio purchases offset by collection proceeds applied to the principal of our receivable portfolios. Receivable portfolio purchases, net of put-backs, were $359.5 million and $362.7 million during the three months ended March 31, 2026 and 2025, respectively. Collection proceeds applied to the principal of our receivable portfolios were $328.4 million and $259.6 million during the three months ended March 31, 2026 and 2025, respectively. Refer to Purchases and Collections within "Item 2: Management's Discussion and Analysis of Financial Condition and Results of Operations" for discussion relating to purchases and collections.

***Financing Cash Flows***

Net cash provided by financing activities was $18.6 million and $40.3 million during the three months ended March 31, 2026 and 2025, respectively. Financing cash flows are generally affected by borrowings under our credit facilities and proceeds from various debt offerings, offset by repayments of amounts outstanding under our credit facilities and repayments of various notes. Borrowings under our credit facilities were $358.0 million and $246.4 million during the three months ended March 31, 2026 and 2025, respectively. Repayments of amounts outstanding under our credit facilities were $304.2 million and $185.8 million during the three months ended March 31, 2026 and 2025, respectively.

***Capital Resources***

Our primary sources of capital are cash collections from our receivable portfolios, bank borrowings, debt offerings, and equity offerings. Depending on the capital markets, we consider additional financings to fund our operations and any potential acquisitions. From time to time, we may repurchase outstanding debt or equity and/or restructure or refinance debt obligations. Our primary cash requirements include funding the purchase of receivable portfolios, operating expenses, the payment of interest and principal on borrowings, the payment of income taxes, funding any entity acquisitions and share repurchases.

We are in material compliance with all covenants under our financing arrangements. See "Note 7: Borrowings" in the notes to our condensed consolidated financial statements for a further discussion of our debt. Available capacity under our Global Senior Facility, was $791.3 million as of March 31, 2026.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

In May 2021, our Board of Directors authorized a $300.0 million share repurchase program. In November 2025, our Board of Directors authorized an increase of an additional $300.0 million under the share repurchase program. Repurchases under this program are expected to be made from cash on hand and/or a drawing from our Global Senior Facility and may be made from time to time, subject to market conditions and other factors, in the open market, through private transactions, block transactions, or other methods as determined by our management and Board of Directors, and in accordance with market conditions, other corporate considerations, and applicable regulatory requirements. The program does not obligate us to acquire any particular amount of common stock, and it may be modified or suspended at our discretion. During the three months ended March 31, 2026 and 2025 , we repurchased 345,548 and 289,425 shares of our common stock for $20.0 million and $10.0 million, respectively, under the share repurchase program. As of March 31, 2026, we had remaining authority to purchase $282.4 million of our common stock. Our practice is to retire the shares repurchased.

Our cash and cash equivalents as of March 31, 2026, consisted of $68.5 million held by U.S.-based entities and $158.7 million held by foreign entities. Most of our cash and cash equivalents held by foreign entities is indefinitely reinvested and may be subject to material tax effects if repatriated. However, we believe that our sources of cash and liquidity are sufficient to meet our business needs in the United States and do not expect that we will need to repatriate the funds.

Included in cash and cash equivalents is cash that was collected on behalf of, and remains payable to, third-party clients. The balance of cash held for clients was $17.1 million as of March 31, 2026.

Cash from operations could also be affected by various risks and uncertainties, including, but not limited to, timing of cash collections from our consumers, and other risks detailed in our Risk Factors. However, we believe that we have sufficient liquidity to fund our operations for at least the next twelve months, given our expectation of continued positive cash flows from operations, our cash and cash equivalents, our access to capital markets, and availability under our credit facilities. Our future cash needs will depend on our acquisitions of portfolios and businesses.

**Critical Accounting Estimates**

Our condensed consolidated financial statements are prepared in accordance with U.S. GAAP. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses, and related disclosures. On an ongoing basis, we evaluate our estimates and assumptions based on historical experience and on various other assumptions that we believe are reasonable under the circumstances. Our actual results could differ from these estimates under different assumptions or conditions. Refer to "Critical Accounting Estimates" contained in Part II, Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2025, for a complete discussion of our critical accounting estimates. Other than the ongoing reassessment of expected future recoveries of our receivable portfolios during each reporting period under our CECL accounting policy as discussed in "Note 5: Receivable Portfolios, Net" to our condensed consolidated financial statements, there have been no material changes to our critical accounting policies and estimates since our Annual Report on Form 10-K for the year ended December 31, 2025.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Item 3 – Quantitative and Qualitative Disclosures About Market Risk**

*Foreign Currency Exchange Rates.* As of March 31, 2026, there had not been a material change in any of the foreign currency risk information disclosed in Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

*Interest Rates.* As of March 31, 2026, there had not been a material change in the interest rate risk information disclosed in Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

**Item 4 – Controls and Procedures**

Attached as exhibits to this Form 10-Q are the certifications required by Rule 13a-14 of the Securities Exchange Act of 1934, as amended. This section includes information concerning the controls and controls evaluation referred to in the certifications.

***Evaluation of Disclosure Controls and Procedures***

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission (the "SEC") and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives and accordingly, management is required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on their most recent evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, are effective at the reasonable assurance level.

***Changes in Internal Control over Financial Reporting***

There were no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**PART II – OTHER INFORMATION**

**Item 1 – Legal Proceedings**

Information with respect to this item may be found in "Note 11: Commitments and Contingencies," to the condensed consolidated financial statements.

**Item 1A – Risk Factors**

There is no material change in the information reported under "Part I-Item 1A-Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

**Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds**

***Issuer Repurchases of Equity Securities***

In May 2021, our Board of Directors authorized a $300.0 million share repurchase program. In November 2025, our Board of Directors authorized an increase of an additional $300.0 million under the share repurchase program. Repurchases under this program are expected to be made from cash on hand and/or a drawing from our Global Senior Facility, and may be made from time to time, subject to market conditions and other factors, in the open market, through private transactions, block transactions, or other methods as determined by management and our Board of Directors, and in accordance with market conditions, other corporate considerations, and applicable regulatory requirements. During the three months ended March 31, 2026, the Company repurchased 345,548 shares of our common stock for $20.0 million. The following table presents information with respect to purchases of common stock of the Company during the three months ended March 31, 2026, by the Company or an "affiliated purchaser" of the Company, as defined in Rule 10b-18(a)(3) under the Exchange Act:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Period** | **Total Number of Shares Purchased** | **Average<br>Price Paid<br>Per Share** | **Total Number of**<br>**Shares Purchased**<br>**as Part of Publicly**<br>**Announced Plans**<br>**or Programs**<sup>(1)</sup> | **Approximate Dollar**<br>**Value of Shares That May**<br>**Yet Be Purchased**<br>**Under the Publicly**<br>**Announced Plans**<br>**or Programs** |
| January 1, 2026 to January 31, 2026 | 236730 | $55.56 | 236730 | $289225971 |
| February 1, 2026 to February 28, 2026 | 77226 | $60.13 | 77226 | $284582457 |
| March 1, 2026 to March 31, 2026 | 31592 | $69.76 | 31592 | $282378557 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Total | 345548 | $57.88 | 345548 | $282378557 |

---

________________________

&nbsp;&nbsp;&nbsp;&nbsp;(1)This column discloses the number of shares purchased pursuant to the program during the indicated time periods.

**Item 5 - Other Information**

On March 10, 2026, Andrew Asch, SVP, General Counsel and Government Affairs, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell up to 9,085 shares of Encore Capital Group, Inc. common stock between June 9, 2026 and March 10, 2027, subject to certain conditions.

On March 11, 2026, John Yung, President International and Cabot Credit Management, adopted a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) to sell up to 4,000 shares of Encore Capital Group, Inc. common stock between June 10, 2026 and March 11, 2027, subject to certain conditions.

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**Item 6 – Exhibits**

---

| | |
|:---|:---|
| **<u>Number</u>** | **<u>Description</u>** |
| 3.1.1 | <u>[Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to Amendment No. 2 to the Company's Registration Statement on Form S-1/A filed on June 14, 1999, File No. 333-77483)](https://www.sec.gov/Archives/edgar/data/1084961/000095015399000768/0000950153-99-000768.txt)</u> |
| 3.1.2 | <u>[Certificate of Amendment to the Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on April 4, 2002, File No. 000-26489)](https://www.sec.gov/Archives/edgar/data/1084961/000101968702000549/mcm_ex3-1.txt)</u> |
| 3.1.3 | <u>[Second Certificate of Amendment to the Certificate of Incorporation (incorporated by reference to Exhibit 3.1.3 to the Company's Quarterly Report on Form 10-Q filed on August 7, 2019)](https://www.sec.gov/Archives/edgar/data/1084961/000108496119000103/ecpg-2019x0630x10qex31.htm)</u> |
| 3.2 | <u>[Amended and Restated Bylaws, as amended through](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[March](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[18](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[, 202](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[6](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[(incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[March](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[20](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[, 202](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[6](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)[)](https://www.sec.gov/Archives/edgar/data/1084961/000108496126000023/ex31amendedbylawsclean.htm)</u> |
| 10.1 | <u>[Non-Employee Director Compensation Program Guidelines, effective June](ecpg-20260331xex101.htm)[12](ecpg-20260331xex101.htm)[, 202](ecpg-20260331xex101.htm)[6](ecpg-20260331xex101.htm)[(filed herewith)](ecpg-20260331xex101.htm)</u> |
| 31.1 | <u>[Certification of the Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)](ecpg-20260331ex311.htm)</u> |
| 31.2 | <u>[Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (filed herewith)](ecpg-20260331ex312.htm)</u> |
| 32.1 | <u>[Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (furnished herewith)](ecpg-20260331ex321.htm)</u> |
| 101.INS | Inline XBRL Instance Document - The instance document does not appear in the interactive data file because XBRL tags are embedded within the inline XBRL document. (filed herewith) |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document (filed herewith) |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith) |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document (filed herewith) |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document (filed herewith) |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith) |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 |

---

In accordance with Item 601(b)(4)(iii)(A) of Regulation S-K, copies of certain instruments defining the rights of holders of long-term debt of the company are not filed herewith. Pursuant to this regulation, we hereby agree to furnish a copy of any such instrument to the SEC upon request.<br>

------

<u>[**Table of Contents**](#i41c4164d9e084f6a9251d45bf30001ea_7)</u>

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
| **ENCORE CAPITAL GROUP, INC.** | **ENCORE CAPITAL GROUP, INC.** |
| By: | /s/ Tomas Hernanz |
|  | Tomas Hernanz |
|  | Executive Vice President, |
|  | Chief Financial Officer and Treasurer<br>(Principal Financial and Accounting Officer) |

---

Date: May 6, 2026

## Exhibit 10.1

**Exhibit 10.1**

**Exhibit 10.1**

**ENCORE CAPITAL GROUP, INC.**

**NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM GUIDELINES**

Approved by the Board of Directors effective June 12, 2026

------

**ENCORE CAPITAL GROUP, INC.**

**NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM GUIDELINES**

**Table of Contents**

Section 1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Definitions

Section 2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Purpose of Guidelines

Section 3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term of Guidelines; Amendment and Termination of Guidelines

Section 4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Administration

Section 5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Eligibility and Participation

Section 6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation

Section 7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Miscellaneous

------

***&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;***

**ENCORE CAPITAL GROUP, INC.**

**NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM GUIDELINES**

1.0**DEFINITIONS**

The following terms shall have the following meanings unless the context indicates otherwise:

1.1 *"2017 Plan"* shall mean the Company's 2013 Incentive Compensation Plan or the 2017 Incentive Award Plan, as applicable, as such plans may be amended, modified, or supplemented from time to time, and any successors to such plans.

1.2 *"Annual Meeting Date"* shall mean the date of the Company's annual meeting of shareholders for a given calendar year.

1.3 *"Beneficiary"* shall mean a beneficiary or beneficiaries designated in writing by a Non-Employee Director to receive any compensation under these Guidelines in the event of a Non-Employee Director's death. If no Beneficiary is designated by the Non-Employee Director, then the Non-Employee Director's estate shall be deemed to be the Non-Employee's Beneficiary.

1.4 *"Board"* shall mean the Board of Directors of the Company.

1.5 *"Business Day"* means any day that is not a Saturday, Sunday, or other day on which banking corporations in San Diego, California, are authorized or required by law to close.

1.6 *"Code"* shall mean the Internal Revenue Code of 1986, as amended from time to time, including applicable regulations promulgated thereunder.

1.7 *"Committee"* shall mean the Board's Compensation Committee.

1.8 *"Company"* shall mean Encore Capital Group, Inc., a Delaware corporation.

1.9 *"Deferred Compensation Plan"* means the Company's Non-Employee Director Deferred Stock Compensation Plan, as such plan may be amended, modified, or supplemented from time to time, and any successor to such plan.

1.10 *"Director Service Year"* shall mean the period beginning on a given Annual Meeting Date and ending on the date immediately preceding the next Annual Meeting Date.

1.11 *"Effective Date"* shall mean June 12, 2026.

1.12 *"Equity Award"* shall mean either a Stock Award or an RSU Award.

------

1.13 *"Equity Award Agreement"* shall mean a written agreement between the Company and a Non-Employee Director that establishes the terms, conditions, restrictions and/or limitations applicable to an Equity Award in addition to those established by these Guidelines and by the Committee's exercise of its administrative powers; *provided, however*, that if a Non-Employee Director defers receipt of any Equity Award pursuant to the Deferred Compensation Plan, then such Non-Employee Director's deferral election, coupled with the terms and conditions set forth in the Deferred Compensation Plan, shall be deemed to constitute an "Equity Award Agreement."

1.14 *"ERISA"* shall mean the Employee Retirement Income Security Act of 1974, as amended from time to time, including applicable regulations promulgated thereunder.

1.15 *"Exchange Act"* shall mean the Securities Exchange Act of 1934, as amended from time to time, including applicable regulations thereunder.

1.16"*Fair Market Value of a Share"* shall mean:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)if Shares are readily tradable on a national securities exchange or other market system, the closing price of a Share on the principal trading market for the Shares on the date of calculation (or on the last preceding trading date if Shares were not traded on such date), or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)if Shares are not readily tradable on a national securities exchange or other market system:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)the book value of a Share as of the last day of the last completed fiscal quarter preceding the date of calculation; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)any other value as otherwise determined in good faith by the Board.

1.17 *"Guidelines"* shall mean the Encore Capital Group, Inc. Non-Employee Director Compensation Program Guidelines.

1.18 *"Non-Employee Director"* shall mean a member of the Board who is not an employee of the Company.

1.19 *"Quarterly Payment Date"* shall mean September 1st, December 1st, March 1st, and June 1st in a given Director Service Year. By way of example, if the Annual Meeting Date for 20XX is June 15, 20XX and the Annual Meeting Date for 20YY is June 16, 20YY, then the "Quarterly Payment Dates" for the Director Service Year beginning on June 15, 20XX and ending on June 16, 20YY will be September 1, 20XX, December 1, 20XX, March 1, 20YY, and June 1, 20YY.

1.20 *"RSU Award"* shall mean an Equity Award granted in the form of restricted stock units, and which shall be paid in Shares to the Non-Employee Director (or to his or her Beneficiary) pursuant to the terms of the Equity Award Agreement evidencing such Equity Award.

1.21 *"Share"* shall mean a share of the Company's common stock, $.01 par value.

------

1.22 *"Stock Award"* shall mean an Equity Award granted in the form of Shares, and which shall be delivered to the Non-Employee Director (or his or her Beneficiary) in accordance with Section 6 below.

1.23 *"Stock Ownership and Retention Guidelines"* means the Company's Stock Ownership and Retention Guidelines as adopted by the Board, as such guidelines may be amended, supplemented, and modified from time to time.

1.24 *"Treasury Regulation"* shall mean the regulations promulgated under the Code by the United States Department of the Treasury, as amended from time to time.

1.25 *"Voting Members"* shall have the meaning set forth in Section 6.4.

2.0**PURPOSE OF GUIDELINES**

2.1**Purpose**. The purpose of these Guidelines is to implement and administer the Company's compensation program for Non-Employee Directors, which was originally adopted by the Board on December 7, 2011; amended by the Committee on May 13, 2014; further amended by the Board on December 17, 2014, effective January 1, 2015; further amended by the Board on April 21, 2016, effective June 1, 2016; further amended by the Board on December 6, 2017, effective on January 1, 2018; further amended by the Board on August 28, 2018, effective on September 1, 2018; further amended by the Board on June 17, 2020; further amended by the Board effective on June 10, 2022; further amended by the Board effective on June 7, 2024, and further amended by the Board effective on the Effective Date.

2.2**ERISA.** The director compensation program is not intended to be an employee benefit plan under ERISA, and thus the program and these Guidelines are intended to not be subject to ERISA.

2.3**Code Section 409A.** The program and these Guidelines are intended to be fully compliant with Code Section 409A.

3.0**TERM OF GUIDELINES; AMENDMENT AND TERMINATION OF GUIDELINES**

3.1**Term**. These Guidelines shall be effective as of the Effective Date and shall terminate only when terminated by the Committee in accordance with <u>Section 3.2</u> below.

3.2**Termination of Guidelines**. The Committee may suspend or terminate these Guidelines at any time with or without prior notice; *provided, however*, that no action authorized by this <u>Section 3.2</u> shall reduce the amount of any outstanding Equity Award or otherwise adversely change the terms and conditions thereof without the Non-Employee Director's prior written consent.

3.3**Amendment of Guidelines**. The Committee may amend these Guidelines at any time with or without prior notice; *provided, however*, that no action authorized by this <u>Section 3.3</u> shall reduce the amount of any outstanding Equity Award or otherwise adversely change the terms and conditions thereof without the Non-Employee Director's prior written consent.

------

3.4**Amendment or Cancellation of Equity Award Agreements**. Subject to the provisions of the 2017 Plan, the Committee may amend or modify any Equity Award Agreement at any time; *provided, however,* that if the amendment or modification adversely affects the Non-Employee Director, such amendment or modification shall be by mutual agreement between the Committee and the Non-Employee Director or such other persons as may then have an interest therein.

3.5**Restrictions to Amendment of Guidelines**. Notwithstanding anything contained in these Guidelines to the contrary, any amendment to these Guidelines or to any Equity Award Agreement that would result in compensation payable under these Guidelines to be subject to the penalty tax imposed by Code Section 409A shall be null and void and of no effect as if these Guidelines had never been amended.

4.0**ADMINISTRATION**

4.1**Responsibility**. The Committee shall have the responsibility, in its sole discretion, to control, operate, manage and administer these Guidelines in accordance with its terms.

4.2**Award Agreement**. Each Equity Award granted under these Guidelines shall be evidenced by an Equity Award Agreement, which shall be signed by an authorized officer of the Company and the Non-Employee Director; provided, however, that in the event of any conflict between a provision of these Guidelines or the 2017 Plan and any provision of an Award Agreement, the provisions of these Guidelines or the 2017 Plan, as the case may be, shall control and prevail.

4.3**Authority of the Committee**. The Committee shall have all the discretionary authority that may be necessary or helpful to enable it to discharge its responsibilities with respect to these Guidelines, including but not limited to the following:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)to determine eligibility for participation in these Guidelines;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)to determine the number of Shares underlying an Equity Award granted under these Guidelines;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)to grant Equity Awards to, and to enter into Award Agreements with, Non-Employee Directors;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)to supply any omission, correct any defect, or reconcile any inconsistency in these Guidelines in such manner and to such extent as it shall deem appropriate in its sole discretion to carry the same into effect;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)to issue administrative guidelines as an aid to administer these Guidelines and make changes in such administrative guidelines as it from time to time deems proper;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)to make rules for carrying out and administering these Guidelines and make changes in such rules as it from time to time deems proper;

------

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)to the extent permitted under these Guidelines, grant waivers of Guidelines terms, conditions, restrictions, and limitations;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)to maintain these Guidelines' full compliance with the 2017 Plan and Code Section 409A; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)to take any and all other actions it deems necessary or advisable for the proper operation or administration of these Guidelines.

4.4**Action by the Committee**. The Committee may act only by a majority of its members. Any determination of the Committee may be made, without a meeting, by a writing or writings signed by all of the members of the Committee. In addition, the Committee may authorize any one or more of its members or an officer of the Company to execute and deliver documents on behalf of the Committee.

4.5**Delegation of Authority**. The Committee may delegate to one or more of its members, or to one or more agents, such administrative duties as it may deem advisable; provided, however, that any such delegation shall be in writing. In addition, the Committee, or any person to whom it has delegated duties under this Section 4.5, may employ one or more persons to render advice with respect to any responsibility the Committee or such person may have under these Guidelines. The Committee may employ such legal or other counsel, consultants and agents as it may deem desirable for the administration of these Guidelines and may rely upon any opinion or computation received from any such counsel, consultant or agent. Expenses incurred by the Committee in the engagement of such counsel, consultant or agent shall be paid by the Company.

4.6**Determinations and Interpretations by the Committee**. All determinations and interpretations made by the Committee shall be binding and conclusive on all Non-Employee Directors and their heirs, successors, and legal representatives.

4.7**Liability**. No member of the Committee and no employee of the Company shall be liable for any act or failure to act hereunder, except in circumstances involving his or her bad faith, gross negligence or willful misconduct, or for any act or failure to act hereunder by any other member or employee or by any agent to whom duties in connection with the administration of these Guidelines have been delegated.

4.8**Indemnification**. The Company shall indemnify members of the Committee and any agent of the Committee against any and all liabilities or expenses to which they may be subjected by reason of any act or failure to act with respect to their duties on behalf of these Guidelines, except in circumstances involving such person's bad faith, gross negligence or willful misconduct.

5.0**ELIGIBILITY AND PARTICIPATION**

5.1**Eligibility**. All Non-Employee Directors shall be eligible to participate in the Company's director compensation program and to receive compensation in accordance with these Guidelines.

------

5.2**Participation**. Each Non-Employee Director shall participate in the Company's director compensation program and receive compensation in accordance with these Guidelines.

5.3**Waiver of Compensation under These Guidelines**. A Non-Employee Director may waive all or a portion of his or her compensation under these Guidelines at any time, provided that such waiver is in writing and provided that such waiver does not violate Code Section 409A.

6.0**COMPENSATION**

6.1**Annual Cash Compensation**. For each Director Service Year, each Non-Employee Director shall receive the following cash compensation for their annual service on the Board:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)An annual cash retainer of $75,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)If the Non-Employee Director is Chairman of the Board, an additional annual cash retainer of $120,000;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)If the Non-Employee Director is the chair of the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, Risk Committee or any other standing committee of the Board, an annual cash retainer of $25,000 for each position as chair;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)If the Non-Employee Director is a member (but not chair) of the Audit Committee, Compensation Committee, Nominating and Corporate Governance Committee, Risk Committee, or any other standing committee established by the Board, an annual cash retainer of $10,000 for each position as member; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)A $1,000 per meeting committee service fee for each committee of the Board on which the Non-Employee Director serves, for any committee meeting starting with the seventh (7th) meeting of such committee in a Director Service Year.

The cash payments under <u>Sections 6.1(a)</u>, <u>6.1(b)</u>, <u>6.1(c)</u>, and <u>6.1(d)</u> shall be paid quarterly, in arrears, as follows: 25% of each applicable payment shall be paid on or before the 5th Business Day following each Quarterly Payment Date for such Director Service Year. On each Quarterly Payment Date in a given Director Service Year, the Company shall determine the number of meetings held by each committee of the Board during such Director Service Year and, if such committee has met seven or more times during such Director Service Year, then the Company will also make cash payments to the members of such committee under <u>Section 6.1(e)</u> on such Quarterly Payment Date. If a Non-Employee Director's service on the Board, on a given committee, or as Chairman of the Board or chair of a committee is less than the entire Director Service Year, then the above amounts shall be prorated to reflect the Non-Employee Director's actual period of service on the Board, on a given committee, or as Chairman of the Board or chair of a given committee.

6.2**Equity Awards**. In addition to the annual cash compensation set forth in Section 6.1, for each Director Service Year, each Non-Employee Director shall receive an annual Equity Award retainer with a grant date fair market value equal to $180,000, to be granted on the 5th Business Day

------

following the Annual Meeting Date for such Director Service Year; provided that if a person becomes a Non-Employee Director on a date other than the Annual Meeting Date for such Director Service Year, then the annual Equity Award retainer amount will be prorated to reflect the number of days remaining in such Director Service Year and the prorated annual Equity Award shall be granted on the 5th Business Day following the date the Non-Employee Director becomes a member of the Board.

6.3**Terms and Conditions of Equity Awards**. The Committee, in its sole discretion, may grant either Stock Awards or RSU Awards, or a combination of both. Equity Awards shall have the following terms and conditions:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)Each Equity Award shall be issued pursuant to and shall be subject to the 2017 Plan.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)Each Equity Award (other than Stock Awards) shall be evidenced by an Equity Award Agreement signed by the Non-Employee Director to whom it is granted and an authorized official of the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)The number of shares underlying each Equity Award shall be determined by dividing the applicable dollar amount of the Equity Award by the Fair Market Value of a Share on the date of grant, rounded down to whole Shares (i.e., any fractional shares shall be disregarded);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)Equity Awards shall be fully vested on the date of grant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e)Subject to the following sentence, all Shares underlying all Equity Awards granted to any Non-Employee Director shall be subject to the Stock Ownership and Retention Guidelines. Notwithstanding the foregoing, however, if the Equity Award is a Stock Award that is not deferred by the Non-Employee Director pursuant to Section 6.6, then the Non-Employee Director may sell a portion of the Shares issued pursuant to such Stock Award equal to an amount that would satisfy statutory minimum federal (including FICA and Social Security), state and local tax withholding requirements;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f)If the award is a Stock Award that is not deferred pursuant to Section 6.6 below, then Shares (including appropriate legends if in certificate form) shall be issued in the Non-Employee Director's name as soon as practicable after the applicable grant date;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g)If the award is an RSU Award that is not further deferred pursuant to Section 6.6 below, Shares underlying such RSU Award shall be issued to the Non-Employee Director within 10 Business Days following the date that the Non-Employee Director is no longer a member of the Board;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h)Stock Awards that have not been deferred pursuant to Section 6.6 shall have full voting and dividend rights in the same manner and to the same extent as such rights are extended to the Company's shareholders; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)RSU Awards shall have no voting rights but shall have dividend equivalent rights as set forth in the Equity Award Agreements for such RSU Awards.

------

6.4**Clawback**. Notwithstanding anything contained in these Guidelines to the contrary, if a Non-Employee Director is determined, in the sole discretion of the affirmative vote of not less than a majority of the entire membership of the Board (excluding the Non-Employee Director whose compensation is at issue) (the "Voting Members"), by a resolution duly adopted by the Voting Members, to have not earned all or a portion of any compensation received from the Company because the Non-Employee Director has acted in a manner that is not in the Company's best interests or has failed to act in a manner that is in the Company's best interests during such member's tenure on the Board or as a result of his or her failure to complete a full term of Board service for any reason, then, at the sole discretion of the Voting Members, any cash or Equity Award, or any portion thereof as determined by the Voting Members, held by such Non-Employee Director, shall as of the date of the adoption of such resolution be subject to forfeiture and all rights of the Non-Employee Director to or with respect to such forfeited cash and/or Equity Award shall terminate. With respect to any cash compensation or Shares actually received by such Non-Employee Director, if so resolved by the Voting Members in accordance with these Guidelines, at the Voting Members' sole discretion, the Non-Employee Director may be required to pay back to the Company all or any portion of such cash compensation or deliver back to the Company all or any portion of such Shares as determined by the Voting Members. In the event that the Voting Members' determination is based upon such Non-Employee Director's action or inaction, as described above, then the Voting Members may consider whether any such repayment shall be assessed based on compensation received either at or after the time of the action or inaction. The Voting Members may also consider, if relevant, whether a prorated amount should be calculated for service rendered as a Board member, if the Non-Employee Director resigns before completing his or her service period as contemplated by periodic compensation payments.

6.5**Expenses**. The Company shall promptly reimburse a Non-Employee Director for his or her reasonable expenses reasonably incurred in connection with his or her service to the Board and the Company, subject to the Company's reimbursement policy and the submission of written receipts or other valid documentation.

6.6**Deferral**. A Non-Employee Director may defer any compensation paid or granted under these Guidelines pursuant to the Deferred Compensation Plan.

6.7**Stock Ownership and Retention Guidelines**. Each Non-Employee Director will be subject to the Company's Stock Ownership and Retention Guidelines.

7.0**MISCELLANEOUS**

7.1**Listing of Awards and Related Matters**. If at any time the Committee determines that the listing, registration or qualification of Equity Awards on any securities exchange or under any applicable law, or the consent or approval of any governmental regulatory authority, is necessary or desirable as a condition of, or in connection with, the granting of an Equity Award, such Equity Award may not be exercised, distributed or paid out, as the case may be, in whole or in part, unless such listing, registration, qualification, consent or approval has been effected or obtained free of any conditions not acceptable to the Committee.

------

7.2**No Right, Title, or Interest in Company Assets**. Non-Employee Directors shall have no right, title, or interest whatsoever in or to any investments that the Company may make to aid it in meeting its obligations under these Guidelines. Nothing contained in these Guidelines, and no action taken pursuant to its provisions, shall create or be construed to create a trust of any kind, or a fiduciary relationship between the Company and any Non-Employee Director, beneficiary, legal representative or any other person. To the extent that any person acquires a right to receive payments from the Company under these Guidelines, such right shall be no greater than the right of an unsecured general creditor of the Company. All payments to be made hereunder shall be paid from the general funds of the Company and no special or separate fund shall be established and no segregation of assets shall be made to assure payment of such amounts except as expressly set forth in these Guidelines.

7.3**No Right to Continued Service**. A Non-Employee Director's rights, if any, to continue to serve the Company as a member of the Board or otherwise shall not be enlarged or otherwise affected by these Guidelines, and the Company reserves the right to terminate the Non-Employee Director's service to the Company in accordance with Company's by-laws.

7.4**Awards Subject to Foreign Laws**. The Committee may grant Equity Awards to individual Non-Employee Directors who are subject to the tax and/or other laws of nations other than the United States, and such Equity Awards may have terms and conditions as determined by the Committee as necessary to comply with applicable foreign laws. The Committee may take any action that it deems advisable to obtain approval of such Equity Awards by the appropriate foreign governmental entity; *provided, however*, that no such Equity Awards may be granted pursuant to this <u>Section 7.4</u> and no action may be taken which would result in a violation of the Exchange Act or any other applicable law.

7.5**Governing Law**. The Guidelines, all cash compensation and Equity Awards granted hereunder, and all actions taken in connection herewith shall be governed by and construed in accordance with the laws of the State of Delaware without reference to principles of conflict of laws, except as superseded by applicable federal law.

\* \* \* \* \*

## Exhibit 31.1

**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER**

I, Ashish Masih, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Encore Capital Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| By: | /S/ ASHISH MASIH |
|  | **Ashish Masih<br>President and Chief Executive Officer** |

---

Date: May 6, 2026

## Exhibit 31.2

**Exhibit 31.2**

**CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER**

I, Tomas Hernanz, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.I have reviewed this Quarterly Report on Form 10-Q of Encore Capital Group, Inc.;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| By: | /S/ TOMAS HERNANZ |
|  | **Tomas Hernanz<br>Executive Vice President, Chief Financial Officer and Treasurer** |

---

Date: May 6, 2026

## Exhibit 32.1

**Exhibit 32.1**

**ENCORE CAPITAL GROUP, INC.**

**CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER**

**PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO**

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection with the Quarterly Report of Encore Capital Group, Inc. (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

&nbsp;&nbsp;&nbsp;&nbsp;(1)The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

&nbsp;&nbsp;&nbsp;&nbsp;(2)The information contained in the Report fairly presents, in all material respects, the consolidated financial condition and results of operations of the Company.

---

| |
|:---|
| /s/ ASHISH MASIH |
| **Ashish Masih** |
| **President and Chief Executive Officer** |

---

May 6, 2026

---

| |
|:---|
| /s/ TOMAS HERNANZ |
| **Tomas Hernanz** |
| **Executive Vice President,<br>Chief Financial Officer and Treasurer** |

---

May 6, 2026

This certification accompanies the above described Report and is being furnished pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed as part of the Report.

<br>